Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides

Hana M. Russo, Joseph Rathkey, Andrea Boyd-Tressler, Michael A. Katsnelson, Derek W. Abbott and George R. Dubyak
J Immunol August 15, 2016, 197 (4) 1353-1367; DOI: https://doi.org/10.4049/jimmunol.1600699
Hana M. Russo
*Department of Pathology, Case Western Reserve University, Cleveland, OH 44106;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Rathkey
*Department of Pathology, Case Western Reserve University, Cleveland, OH 44106;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Boyd-Tressler
†Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea Boyd-Tressler
Michael A. Katsnelson
*Department of Pathology, Case Western Reserve University, Cleveland, OH 44106;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek W. Abbott
*Department of Pathology, Case Western Reserve University, Cleveland, OH 44106;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Derek W. Abbott
George R. Dubyak
*Department of Pathology, Case Western Reserve University, Cleveland, OH 44106;
†Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106; and
‡Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for George R. Dubyak
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Abstract

Canonical inflammasome activation induces a caspase-1/gasdermin D (Gsdmd)–dependent lytic cell death called pyroptosis that promotes antimicrobial host defense but may contribute to sepsis. The nature of the caspase-1–dependent change in plasma membrane (PM) permeability during pyroptotic progression remains incompletely defined. We assayed propidium2+ (Pro2+) influx kinetics during NLRP3 or Pyrin inflammasome activation in murine bone marrow–derived macrophages (BMDMs) as an indicator of this PM permeabilization. BMDMs were characterized by rapid Pro2+ influx after initiation of NLRP3 or Pyrin inflammasomes by nigericin (NG) or Clostridium difficile toxin B (TcdB), respectively. No Pro2+ uptake in response to NG or TcdB was observed in Casp1−/− or Asc−/− BMDMs. The cytoprotectant glycine profoundly suppressed NG and TcdB-induced lysis but not Pro2+ influx. The absence of Gsdmd expression resulted in suppression of NG-stimulated Pro2+ influx and pyroptotic lysis. Extracellular La3+ and Gd3+ rapidly and reversibly blocked the induced Pro2+ influx and markedly delayed pyroptotic lysis without limiting upstream inflammasome assembly and caspase-1 activation. Thus, caspase-1–driven pyroptosis requires induction of initial prelytic pores in the PM that are dependent on Gsdmd expression. These PM pores also facilitated the efflux of cytosolic ATP and influx of extracellular Ca2+. Although lanthanides and Gsdmd deletion both suppressed PM pore activity and pyroptotic lysis, robust IL-1β release was observed in lanthanide-treated BMDMs but not in Gsdmd-deficient cells. This suggests roles for Gsdmd in both passive IL-1β release secondary to pyroptotic lysis and in nonlytic/nonclassical IL-1β export.

Introduction

Caspase-1 and murine caspase-11 (caspase-4/5 in humans) mediate a lytic, inflammatory mode of cell death known as pyroptosis. Active caspase-1 is generated by proximity-induced autocatalytic cleavage of procaspase-1 after the assembly and oligomerization of a canonical inflammasome complex that occurs in response to a wide variety of cellular stressors and microbial stimuli. A noncanonical inflammasome involves the direct binding of the lipid A portion of LPS to procaspase-11, which facilitates procaspase-11 oligomerization and proximity-induced autocatalytic cleavage to form active caspase-11 (1). Caspase-1, but not caspase-11, is also required to process the inflammatory cytokines pro–IL-1β and pro–IL-18 into their mature forms. Depending on myeloid cell type or mode of inflammasome activation, IL-1β may be released passively as a secondary consequence of pyroptotic cell lysis or through incompletely defined nonclassical export pathways that are independent of cell lysis (2–5).

Pyroptosis is an effective immune defense mechanism against intracellular bacterial infection. It allows for the removal of intracellular bacteria from their replicative niche and their subsequent detection and efficient clearance by recruited neutrophils (6). However, if the extent of host cell pyroptosis becomes excessive, it can contribute to sepsis and septic shock. Vance and colleagues (7) reported that NLRC4 inflammasome-induced pyroptotic signaling in response to the rapid cytosolic delivery of bacterial flagellin involved Ca2+ influx and massive eicosanoid biosynthesis and release, which led to enhanced vascular permeability and septic shock in mice. Notably, caspase-11–dependent pyroptosis is a critical mediator of LPS-induced lethal sepsis in mice (8–10).

In the context of HIV infection and chronic inflammatory conditions, pyroptosis can also be deleterious to the host. During HIV infection, incomplete DNA transcripts from nonproductively infected CD4+ T cells can be recognized by the IFI16 inflammasome resulting in pyroptosis; this causes massive CD4+ T cell loss and chronic inflammation (11). Pyroptosis can also promote chronic inflammation by providing a lytic pathway for release of apoptosis-associated speck-like protein with a CARD (ASC) specks, which are active inflammasome complexes based on stable polymerized assemblies of the adaptor protein ASC (12). These externalized ASC specks enable continued processing of IL-1β and propagate inflammasome activation after their internalization by bystander phagocytes (12).

Recently, gasdermin D (Gsdmd) was identified as a downstream substrate of caspase-1/11/4/5 that is sufficient to execute pyroptotic cell death (13, 14). Gsdmd is a soluble, cytosolic protein with no apparent transmembrane-spanning region. In humans, it is the product of one of four members of the GSDM gene family (GSDMA, GSDMB, GSDMC, and GSDMD) (15), whereas the murine genome includes Gsdma1-3, Gsdmc1-4, and Gsdmd. GSDM and Gsdm genes are mostly expressed in skin and intestinal epithelial cells (15); murine Gsdmd, in particular, is highly expressed in the small intestine and spleen (15). GSDMD is the only human gasdermin family protein that has a caspase-1/11/4/5 cleavage site; the cleavage sites in human GSDMD and murine Gsdmd are similar but not identical (13).

Caspase-1/11 cleavage of Gsdmd relieves an autoinhibitory interaction between its N and C termini, such that the N-terminal fragment can mediate lytic cell death (13). Cleavage of Gsdmd by caspase-1 requires caspase-1 recruitment into active inflammasomes but not full processing of caspase-1 (16); this is consistent with an earlier study demonstrating that partially cleaved caspase-1 efficiently mediates NLRC4 inflammasome-dependent pyroptosis (17). In addition to mediating pyroptotic cell death, Gsdmd is also necessary for maximal IL-1β release (13, 14, 16).

Despite the requirement for Gsdmd in caspase-1/11–dependent pyroptosis, the specific mechanism(s) by which Gsdmd induces lytic cell death is incompletely defined. After caspase-1/11 activation and Gsdmd cleavage, plasma membrane (PM) integrity becomes compromised leading to a perturbation in ion homeostasis, osmotic swelling and lysis, and the release of various inflammatory mediators (18). DNA fragmentation occurs during pyroptosis but is not required for the execution of pyroptotic cell death (19). Earlier studies by Fink and Cookson (19) reported the formation of PM pores with a diameter of 1.1–2.4 nm during Salmonella typhimurium–dependent caspase-1 activation in macrophages; formation of the pores correlated with osmotic swelling and lysis. However, the molecular identity of these caspase-1–induced pyroptotic pore(s) remains unknown.

In this study, we investigated the molecular and pharmacological properties of the caspase-1–dependent pyroptotic pores by using two canonical inflammasome model systems, the bacterial ionophore nigericin (NG) to engage NLRP3 inflammasomes and Clostridium difficile toxin B (TcdB) to engage Pyrin inflammasomes, in conjunction with kinetic analysis of propidium2+ (Pro2+) dye influx as a readout of pore activity. We now report that caspase-1 activation rapidly induces a PM pore that is nonselectively permeable to large organic cations and anions, and is activated before pyroptotic cell lysis. Induction of this pore is critically dependent on the expression of Gsdmd, whereas its function as an ion-permeable conduit is rapidly and reversibly inhibited by the broadly acting channel inhibitors, La3+ and Gd3+. These data suggest that caspase-1 cleavage of Gsdmd licenses its function as either a direct pore-forming protein, a chaperone that facilitates efficient pyroptotic pore insertion in the PM, or as a regulator that gates a PM-resident large-pore ion channel. Although lanthanides and Gsdmd deletion both suppressed PM pore activity and pyroptotic lysis, robust IL-1β release was observed in lanthanide-treated BMDMs but not in Gsdmd-deficient cells. This may indicate roles for Gsdmd in both passive IL-1β release secondary to pyroptotic lysis and nonlytic/nonclassical IL-1β export.

Materials and Methods

Reagents

Key reagents and their sources were are follows: Escherichia coli LPS serotype O1101:B4 (List Biological Laboratories), NG (APExBio), TcdB (List Biological Laboratories), glycine (Fisher), GdCl3 (Sigma-Aldrich), LaCl3 (Fisher), trovafloxacin (Sigma-Aldrich), P2X7R antagonists A10606120 and A438079 (Tocris Bioscience), ruthenium red (Tocris Bioscience), NS8593 (Sigma-Aldrich), zVAD-fmk and zDEVD-fmk (APExBio), disuccinimidyl suberate (DSS; Sigma-Aldrich), anti–caspase-1 (p20) mouse mAb (AG-20B-0042) (Adipogen), anti-GSDMDC1 mouse mAb (A-7), anti-ASC rabbit polyclonal Ab (N-15), anti–β-actin goat polyclonal Ab (C-11), and all HRP-conjugated secondary Abs (Santa Cruz Biotechnology), murine IL-1β ELISA kit (Biolegend), Fluo-4-AM (Life Technologies), probenecid and trovafloxacin (Sigma-Aldrich), propidium iodide (Life Technologies), YoPro-1 iodide (Life Technologies), ethidium homodimer (EthD)-2 iodide (Life Technologies), adenosine 5′-(α,β-methylene)-diphosphate (Jena Bioscience), phosphoenolpyruvate, lyophilized Firefly luciferase ATP assay mix, Firefly luciferase ATP assay buffer, pyruvate kinase (P-1506) and myokinase (M-3003) (Sigma-Aldrich), and lactate dehydrogenase (LDH) cytotoxicity detection kit (Roche). Anti–IL-1β mouse mAb was provided by the Biological Resources Branch, National Cancer Institute, Frederick Cancer Research and Development Center (Frederick, MD).

Murine macrophage models and cell culture

Wild-type (WT) C57BL/6 mice were purchased from Jackson Labs. Mice lacking both caspase-1 and caspase-11 on a C57BL/6 background (Casp1/11−/−) have been previously described (8, 20, 21). Asc−/− and Nlrp3−/− (C57BL/6 background) mice were provided by Eric Pearlman and Amy Hise (Case Western Reserve University). P2rx7−/− mice have been previously described (5). All experiments and procedures involving mice were approved by the Institutional Animal Care and Use Committee of Case Western Reserve University. Bone marrow–derived macrophages (BMDMs) were isolated from 9- to 12-wk-old mice euthanized by CO2 inhalation. Femurs and tibiae were removed and briefly immersed in 70% ethanol. Bones were then flushed with PBS to remove marrow cavity plugs. Bone marrow cells were resuspended in DMEM (Sigma-Aldrich) supplemented with 10% bovine calf serum (HyClone Laboratories), 100 U/ml penicillin, 100 μg/ml streptomycin (Invitrogen), 2 mM l-glutamine (Lonza), and 30% L cell conditioned medium (which contains the M-CSF necessary for BMDM differentiation), and then plated on 150-mm dishes and cultured in the presence of 10% CO2. Day 3 postisolation, 80% of medium containing nonadherent cells was centrifuged at 300 × g for 5 min and resuspended and replated with fresh BMDM media. Day 5 postisolation, BMDMs were refed, and on day 6, BMDMs were detached with PBS containing 10 mM of EDTA and 4 mg/ml lidocaine, replated on 6-, 12-, or 24-well plates at 1 × 106 cells/ml, and used within 4 d.

NLRP3-FLAG overexpressing, ASC-mCerulean immortalized NLRP3 knockout murine macrophages were provided by Eicke Latz (University of Bonn, Bonn, Germany). Immortalized murine BMDMs (iBMDMs) were cultured in DMEM (Sigma-Aldrich) supplemented with 10% heat-inactivated bovine calf serum (HyClone Laboratories), 100 U/ml penicillin, 100 μg/ml streptomycin (Invitrogen), and 2 mM l-glutamine (Lonza). iBMDMs were plated on 6- or 24-well plates at 1 × 106 cells/ml and used within 2 d.

Generation of CRISPR Gsdmd−/− iBMDMs

A CRISPR-Cas9 guide against Gsdmd was inserted into the lentiCRISPRv2 plasmid (22, 23) with puromycin resistance protein replaced with a hygromycin resistance cassette (Chirieleson et al., manuscript in preparation). CRISPR oligonucleotides were as follows: Gsdmd guide 1-F 5′-CACCGCAGAGGCGATCTCATTCCGG-3′, Gsdmd guide 1-R 5′-AAACCCGGAATGAGATCGCCTCTGC-3′, Gsdmd guide 2-F 5′- CACCGTGAAGCTGGTGGAGTTCCGC-3′, Gsdmd guide 2-R 5′-AAACGCGGAACTCCACCAGCTTCAC-3′. Plasmid lentiCRISPRv2 containing each guide were cotransfected into 293T cells with packaging plasmids PsPax and PMD2. iBMDMs were transduced with virus for 2 d and selected with hygromycin. Clonal cells were isolated and loss of Gsdmd verified by Western blot.

Priming and stimulation of BMDMs and iBMDMs

BMDMs and iBMDMs were primed with 1 μg/ml LPS for 3–4 h at 37°C. LPS containing media was then replaced with a Ca2+-containing balanced salt solution (BSS) (130 mM NaCl, 4 mM KCl, 1.5 mM CaCl2, 1 mM MgCl2, 25 mM Na HEPES, 5 mM d-glucose [pH 7.4]). BSS contained 0.1% BSA for all assays except for Western blot sample preparation, which contained 0.01% BSA. BMDMs and iBMDMs were stimulated with 10 μM of NG or 0.4 μg/ml TcdB for varying lengths of time as indicated. For lanthanide inhibition studies, BMDMs and iBMDMs were treated with indicated concentrations of La3+ or Gd3+ upon stimulation with NG or 20 min after stimulation with TcdB, which is after the toxin has been internalized, but before pyroptotic pore opening.

Western blot analyses and ASC oligomerization assay

LPS-primed BMDMs and iBMDMs in six-well plates (2 × 106 cells/well) were treated as indicated in the presence of BSS containing 0.01% BSA. After 30-min NG stimulation or 45-min TcdB stimulation, detergent soluble cell lysates and extracellular medium (ECM) fractions were prepared as previously described (24) for standard processing by SDS-PAGE, transfer to polyvinylidene fluoride membrane, and Western blot analysis. In brief, to prepare the detergent soluble cell lysate, 56 μl of radioimmunoprecipitation assay lysis buffer (0.5% sodium deoxycholate, 0.1% SDS, 1% IgePal CA630 in PBS, pH 7.4, plus protease inhibitor mixture) was added to adherent cells on the six-well plate and incubated on ice for 5 min. Lysed adherent cells were scraped with a rubber policeman and incubated on ice for 15 min. The whole cell lysate was centrifuged at 15,000 × g for 15 min at 4°C to separate the detergent soluble from insoluble fraction. ASC oligomeric complexes were detected in the insoluble fraction as described previously (24). Primary Abs were used at the following concentrations: 5 μg/ml for IL-1β, 1 μg/ml for caspase-1, 0.4 μg/ml for ASC, 0.2 μg/ml for β-actin, 0.4 μg/ml for Gsdmd, and HRP-conjugated secondary Abs were used at a final concentration of 0.13 μg/ml. Chemiluminescent images of Western blots were developed using a FluorChemE processor (Cell Biosciences).

Pro2+, YoPro2+, EthD4+ influx assays of pyroptotic PM permeabilization

LPS-primed or nonprimed (as indicated) BMDMs and iBMDMs in 24-well plates (5 × 105 cells/well) were briefly washed with PBS before adding BSS supplemented either with 1 μg/ml Pro2+, 2 μM EthD4+, or 1 μM YoPro2+ to each well. Baseline fluorescence (540 nm excitation → 620 nm emission for Pro2+ or EthD4+; 485 nm excitation → 540 nm emission for YoPro2+ at 30-s intervals) was first recorded with a Synergy HT plate reader (BioTek) preheated to 37°C for 5 min. Cells were routinely stimulated with 10 μM NG or 0.4 μg/ml TcdB in the presence or absence of 5 mM glycine for 45 or 60 min, respectively, and the changes in fluorescence were recorded every 30 s. In some experiments with GsdmD-deficient iBMDMs, the NG stimulation was extended to 2 or 3 h; where indicated, some wells were supplemented with 50 μM zVAD-fmk, 50 μM zDEVD-fmk, or 30 μM trovafloxacin. Dye uptake assays were terminated by permeabilizing the PM with digitonin (50 μg/ml) to quantify maximum fluorescence. Fluorescence was expressed as a percentage of maximum fluorescence measured in digitonin-permeabilized cells after subtraction of basal intrinsic fluorescence.

For certain Pro2+ assays, BMDMs or iBMDMs were treated with indicated concentrations of La3+ or Gd3+ in the presence or absence of 5 mM glycine. Wells containing Pro2+, NG, and La3+/Gd3+ were briefly washed with PBS (to remove the lanthanides) 15 min post-NG stimulation and replaced with fresh BSS containing 1 μg/ml Pro2+ to address whether lanthanides reversibly inhibit the pyroptotic pore. To further investigate the mechanism of lanthanide inhibition of pyroptotic pores, we added La3+/Gd3+ and Pro2+ at different times during NLRP3 or Pyrin inflammasome signaling, which include the following experimental setups: 1) Pro2+ added at the same time as NG/TcdB, and La3+/Gd3+ added at the same time as NG or 20 min post-TcdB; 2) Pro2+ added at the same time as NG/TcdB, and La3+/Gd3+ added 20 min post-NG or 30 min post-TcdB; or 3) La3+/Gd3+ added 20 min post-NG or 30 min post-TcdB, and Pro2+ added 5 min post-La3+/Gd3+ addition.

Cytotoxicity assay (LDH release)

LPS-primed BMDMs and iBMDMs in 24-well plates (5 × 105 cells/well) were treated as indicated at 37°C. Supernatants were removed and centrifuged at 15,000 × g for 15 s to pellet detached cells. Cell-free supernatants were assayed for LDH activity (Roche Applied Science) according to the manufacturer’s protocol. The released LDH was expressed as a percentage of total LDH content after 2% Triton X-100 induced permeabilization of unstimulated LPS-primed cells.

Fluo-4 assay of cytosolic [Ca2+]

LPS-primed BMDMs in 24-well plates (5 × 105 cells/well) were loaded with fluo-4-AM and assayed for NG- or TcdB-induced changes in cytosolic [Ca2+] as described previously (25) using the Synergy HT reader preheated to 37°C. The changes in fluo-4 fluorescence were used to calculate cytosolic [Ca2+] by standard calibration methods (26).

Measurement of released adenine nucleotides

LPS-primed BMDMs in 12-well plates (1 × 106 cells/well) were stimulated with 10 μM of NG in the presence of the CD73 inhibitor adenosine 5′-(α,β-methylene)-diphosphate (50 μM) (to prevent the metabolism of AMP to adenosine) and in the presence or absence of 5 mM of glycine at 37°C. At the indicated times, supernatants were removed and centrifuged at 12,200 × g for 15 s to pellet cells. Cell-free supernatants were assayed for total adenine nucleotide content (ATP+ADP+AMP) as described previously (27).

Data processing and analysis

All experiments were repeated two to eight times with separate BMDM preparations. Figures illustrating Western blot results are from representative experiments. Figures illustrating quantified changes in pyroptotic dye influx, extracellular LDH activity, cytosolic [Ca2+], or extracellular [adenine nucleotide] represent the means (± SE) from one to six independent experiments. Quantified data were statistically evaluated by one-way ANOVA with a Bonferroni posttest using Prism 6.0 software.

Results

A rapidly induced propidium influx is triggered downstream of inflammasome activation but upstream of pyroptotic cell lysis

Previous studies have assayed the uptake of cationic DNA-intercalating fluorescent dyes after the activation of a canonical inflammasome complex as an indicator of caspase-1–induced PM permeabilization or pyroptosis (19, 28, 29). Normally, these dyes are impermeant to an intact PM. However, upon perturbation of normal PM barrier function, these dyes can access the nucleus, intercalate with DNA, and fluoresce. PM permeabilization can occur through: 1) frank lysis, 2) the gating of resident large-pore channels, or 3) the insertion of large protein pores that can accommodate the molecular dimensions of these dyes. Case et al. (29) previously used a real-time, kinetic assay of Pro2+ (molecular mass 415 Da) influx to track the progression of pyroptosis in Legionella-infected macrophages. We adapted a similar protocol to investigate the nature and kinetics of caspase-1–induced PM permeabilization during NLRP3 and Pyrin inflammasome activation in murine BMDMs.

To activate the NLRP3 inflammasome, we stimulated BMDMs with the bacterial ionophore NG, which functions as a K+/H+ exchanger after insertion in the PM and organellar membranes. Insertion of NG into the PM results in a decrease in cytosolic [K+], which is a necessary signal for NLRP3 inflammasome complex assembly (30, 31). We previously reported that after an ∼12-min delay, NG-stimulated murine bone marrow–derived dendritic cells (BMDCs) exhibit robust and rapid caspase-1–dependent Pro2+ influx (25). WT BMDMs stimulated with NG displayed similarly rapid Pro2+ influx after a 10- to 12-min delay with ∼60% of the BMDMs accumulating dye by 45 min (Fig. 1A). Pro2+ influx was absent in Nlrp3−/−, Asc−/−, and Casp1−/− (also deficient in caspase-11) BMDMs (Fig. 1A), demonstrating that Pro2+ uptake is dependent on NLRP3 inflammasome components and caspase-1 activation.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

A rapidly induced propidium influx is triggered downstream of inflammasome activation but upstream of pyroptotic cell lysis. (A) WT, Asc−/−, Casp1−/−, and Nlrp3−/− BMDMs were primed with LPS (1 μg/ml) for 4 h before stimulation with NG (10 μM) for 45 min, and the change in PM permeability to Pro2+ (1 μg/ml) and subsequent accumulation of fluorescent Pro2+ (molecular mass 416 Da) complexed with DNA was quantified every 3 min. A 5-min baseline fluorescent read was performed before stimulation, and Pro2+ fluorescence was expressed as a percentage of maximum fluorescence after adding digitonin (50 μg/ml). These data represent the mean ± SE of 6–12 replicates from 4 (WT) or 2 (Asc−/−, Casp1−/−, and Nlrp3−/−) independent experiments. (B) LPS-primed WT, Asc−/−, Casp1−/−, and Nlrp3−/− BMDMs were stimulated with TcdB (0.4 μg/ml) for 60 min, and Pro2+ fluorescence was quantified every 4 min as described in (A). These data represent the mean ± SE of three to nine replicates from three (WT), two (Asc−/− and Casp1−/−), or one (Nlrp3−/−) independent experiment. (C) LPS-primed WT BMDMs were stimulated with NG or (D) TcdB in the presence or absence of the cytoprotectant glycine (5 mM). At the indicated times, supernatants were assayed for LDH activity, which was used as an indicator of lytic LDH release. The absorbance values were expressed as a percentage of maximum absorbance after Triton X-100–induced permeabilization of unstimulated LPS-primed cells. These data represent the mean ± SE of four replicates from two independent experiments. (E) LPS-primed WT BMDMs were stimulated with NG for 45 min or (F) TcdB for 60 min in the presence or absence of 5 mM of glycine, and Pro2+ fluorescence was quantified every 3 or 4 min, respectively. These data represent the mean ± SE of six replicates from two independent experiments.

To address whether this caspase-1–dependent PM permeability pathway is conserved among canonical inflammasome platforms, we also used a Pyrin inflammasome model. To activate the Pyrin inflammasome, we stimulated BMDMs with TcdB. TcdB is one of the main virulence factors involved in the pathogenesis of a C. difficile bacterial infection (32, 33), a major cause of hospital-acquired, antibiotic-associated infectious diarrhea and pseudomembranous colitis (34, 35). TcdB-induced Pyrin inflammasome activation requires effective internalization of the toxin into the cytosol followed by TcdB-dependent glycosylation and inactivation of Rho-GTPases (36). After an ∼20-min delay, WT BMDMs stimulated with TcdB exhibited rapid and robust Pro2+ influx with ∼40% of the cells accumulating dye by 60 min (Fig. 1B). Pro2+ influx was almost completely suppressed in Asc−/− and Casp1−/− BMDMs throughout the 60-min TcdB stimulation, but remained intact in Nlrp3−/− BMDMs (Fig. 1B); this demonstrates that TcdB-induced Pro2+ uptake is dependent on Pyrin inflammasome components.

We next determined whether caspase-1–induced PM permeabilization indicates a prelytic event, like pore/channel opening, or cell lysis. Early studies by Cookson and colleagues (19, 37, 38) found that the cytoprotectant glycine protected Salmonella-infected macrophages from end-stage lysis but did not suppress uptake of ethidium+, a smaller (314 Da) DNA-intercalating dye. We have also reported the use of glycine to suppress caspase-1–induced lysis of macrophages stimulated with maitotoxin (39) or extracellular ATP (40). Notably, millimolar concentrations of glycine have also been used to characterize maitotoxin and palytoxin-induced changes in PM permeability of endothelial cells (41, 42), as well as the pyroptotic responses in macrophages (19). In all of these models of regulated cell death, glycine was shown to prevent or greatly delay end-stage lysis (19, 41, 42).

We adapted these protocols to dissociate lytic from nonlytic propidium uptake by BMDMs in response to NLRP3 and Pyrin inflammasome activation. Stimulation of WT BMDMs with NG or TcdB in the presence of 5 mM of glycine prevented the lytic release of the large macromolecule LDH (140 kDa) (Fig. 1C, 1D), but permitted the influx of Pro2+ with a similar kinetic as in the absence of glycine (Fig. 1E, 1F). This temporal dissociation between the uptake of Pro2+ and the release of LDH in the presence of glycine indicates that Pro2+ influx reflects an event before cell lysis, such as the insertion or opening of a “pyroptotic pore.”

NLRP3 and Pyrin inflammasome activation licenses the opening of a large, nonselective cation- and anion-permeable pyroptotic pore

We next characterized the permeability properties of this putative pyroptotic pore. Previous studies by Cookson and colleagues (19) on pyroptosis in Salmonella-infected macrophages indicated the accumulation of 1.1- to 2.4-nm diameter pores that facilitated the influx of molecules in the 500–1450 Da mass range. A range of DNA-intercalating cationic dyes with different masses, charges, and shapes can be used to probe the dimensions of pyroptotic pores (Supplemental Table I). To define the pores induced by NLRP3 or Pyrin inflammasomes, we assessed permeability to the larger and more highly charged EthD-2 dye (EthD4+; molecular mass 785 Da). After an ∼10- to 12-min delay, WT BMDMs stimulated with NG exhibited a rapid and robust EthD4+ influx that was absent in Casp1−/− BMDMs; this was similar to the WT BMDM Pro2+ influx response, albeit with a slower rate of dye uptake (Fig. 2A). WT BMDMs stimulated with TcdB also exhibited rapid and robust EthD4+ influx after an ∼20-min delay similar to the Pro2+ influx profile (Fig. 2B).

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

NLRP3 and Pyrin inflammasome activation licenses the opening of a large, nonselective cation- and anion-permeable pyroptotic pore. (A) LPS-primed WT and Casp1−/− BMDMs were stimulated with NG (10 μM) for 45 min, and Pro2+ (molecular mass 416 Da) and EthD4+ (molecular mass 788 Da, 2 μM) fluorescence were quantified every 3 min as described in Fig. 1. These data represent the mean ± SE of five to six replicates from two independent experiments. (B) LPS-primed WT BMDMs were stimulated with TcdB (0.4 μg/ml) for 60 min, and Pro2+ and EthD4+ fluorescence were quantified every 4 min. These data represent the mean ± SE of six replicates from two independent experiments. (C) LPS-primed WT BMDMs were stimulated with NG for 45 min or (D) TcdB for 60 min in the presence or absence of 5 mM of glycine, and EthD4+ fluorescence was quantified every 3 or 4 min, respectively. These data represent the mean ± SE of five to six replicates from two independent experiments. (E) LPS-primed WT and Casp1−/− BMDMs were stimulated with NG or (F) TcdB for 60 min, and the change in cytosolic [Ca2+] was determined using the fluo-4-AM (1 μM) Ca2+ indicator dye. A 10-min baseline read was taken before stimulation. These data represent the mean ± SE of six replicates from two independent experiments. (G) LPS-primed WT and Casp1−/− BMDMs were stimulated with NG and TcdB in the presence or absence of 5 mM of glycine for 60 min, and the cytosolic [Ca2+] was determined as described in (E) and (F). These data represent the mean ± SE of three to four replicates from two independent experiments. (H) LPS-primed WT and Casp1−/− BMDMs were stimulated with NG in the presence or absence of 5 mM of glycine. At the indicated times, supernatants were assayed for extracellular [adenine nucleotide] by first rephosphorylating ATP metabolites to ATP and then using a luciferase-based assay to quantify extracellular [ATP]. These data represent the mean ± SE of four replicates from two independent experiments. *p < 0.05.

We verified that the inflammasome-induced permeability to EthD4+ was also a prelytic event by assessing EthD4+ permeability in the presence of glycine. After the stimulation of WT BMDMs with NG or TcdB, the EthD4+ uptake profiles were similar in the presence and absence of glycine (Fig. 2C, 2D); this indicated that the induced pyroptotic pore is permeable to the larger EthD4+ dye, and thus accommodates large organic molecules in the 800-Da mass range. In contrast, Fink and Cookson (19) observed that EthD4+ did not permeate the pyroptotic pore induced in Salmonella-infected macrophages. This discrepancy might indicate that pores of varying dimensions can accumulate during pyroptotic induction by different inflammasome subtypes or that pyroptotic pore induction and its dimensions vary dynamically depending on the rate and extent of active caspase-1 accumulation. Indeed, Gaidt et al. (4) recently reported that stimulation of human monocytes with LPS alone induced distinct NLRP3-dependent inflammasomes that did not drive pyroptotic lysis, whereas stimulation of the same monocytes with LPS plus NG resulted in robust NLRP3 inflammasome-dependent pyroptosis.

Given the pyroptotic pore’s permeability to large organic cations, we next characterized its ability to act as a conduit for inorganic cations or organic anions. To assess the permeability of the pore to Ca2+, we loaded fluo-4 Ca2+ indicator dye into BMDMs before acute induction of NLRP3 or Pyrin inflammasomes. WT BMDMs stimulated with NG exhibited a modest and gradual increase in cytosolic [Ca2+] after a 10- to 12-min delay, and this response was absent in Casp1−/− BMDMs (Fig. 2E). We previously reported similar caspase-1–dependent increases in cytosolic [Ca2+] in NG-stimulated BMDCs and demonstrated that this involved influx of extracellular Ca2+ rather than mobilization of intracellular Ca2+ stores (25). WT BMDMs stimulated with TcdB also demonstrated a gradual increase in cytosolic [Ca2+] after an ∼20-min delay that was greatly suppressed in Casp1−/− BMDMs (Fig. 2F). The onset of Ca2+ influx temporally correlated with the onset of Pro2+ influx in both inflammasome models; this suggests that the increase in cytosolic [Ca2+] is predominantly mediated by the induced pyroptotic pore. That the Ca2+ influx profiles of WT BMDMs in response to NG or TcdB were similar in the presence and absence of glycine (Fig. 2G) indicates that Ca2+ influx, like Pro2+ and EthD4+ uptake, reflects a prelytic change in PM permeability.

To assess whether the pyroptotic pore is also permeable to anions, particularly intracellular metabolites such as ATP, the ECM from WT and Casp1−/− BMDMs stimulated with NG was assayed for total adenine nucleotide (ATP+ADP+AMP) content. The collected samples were treated with a mixture of myokinase, pyruvate kinase, and phosphoenolpyruvate to convert extracellular AMP and ADP to ATP, and a luciferase-based assay was used to determine [ATP]. We were particularly interested in whether the pyroptotic pore is permeable to ATP because this nucleotide is an important danger-associated molecular pattern that activates innate immune cells for support of adaptive immune responses (43, 44) and also promotes leukocyte chemotaxis (45). In the absence or presence of glycine, NG-stimulated WT BMDMs progressively released comparable amounts of adenine nucleotides after an ∼10-min delay, and this release was absent in Casp1−/− BMDMs (Fig. 2H). This indicates that adenine nucleotides are released through a caspase-1–induced pore rather than as a secondary consequence of cell lysis. Taken together, these results indicate that caspase-1 activation induces a large nonselective cation- and anion-permeable pore in the macrophage PM that precedes overt cell lysis.

Gsdmd is required for caspase-1 induction of both the prelytic pyroptotic pores and the subsequent pyroptotic lysis

Because Gsdmd was recently identified as a downstream target of caspase-1/11 with the resulting N-terminal cleavage product being necessary to execute pyroptotic cell death (13, 14, 16), we hypothesized that Gsdmd was also required to induce the pyroptotic pore/channel. He et al. (16) used end-point fluorescence imaging to demonstrate NG-stimulated Pro2+ staining in control but not Gsdmd-deficient murine macrophages. However, those single-time-point images at 60 min did not distinguish between prelytic versus postlytic dye accumulation. We used Gsdmd-targeting guide RNAs (gRNAs) and iBMDMs to generate CRISPR-Cas9 Gsdmd−/− iBMDM cell lines (Fig. 3A). Pooled iBMDM clones generated with two separate gRNAs (Gsdmd G1 and Gsdmd G2) lacked immunoreactive Gsdmd protein and were used for subsequent experiments (Fig. 3B). In response to NG stimulation, LPS-primed Gsdmd−/− G1 and Gsdmd−/− G2 iBMDMs exhibited no Pro2+ uptake at early time points, whereas the parental WT iBMDMs and WT iBMDMs transduced with a nontargeting gRNA (NTG) displayed robust Pro2+ uptake that was markedly suppressed by the pan-caspase inhibitor zVAD (Fig. 3C). As expected, Gsdmd was also necessary for downstream lysis because Gsdmd−/− G1 and Gsdmd−/− G2 iBMDMs exhibited complete suppression of LDH release after 30 or 60 min of NG stimulation (Fig. 3D); such blockade of pyroptosis is consistent with previous findings (13, 16). We also verified that glycine retards the lytic release of LDH 30 min post-NG stimulation in WT iBMDMs similarly to its effect on WT primary BMDMs (Supplemental Fig. 1A). These data demonstrate that Gsdmd is required to induce the upstream prelytic pyroptotic pore/channel that mediates Pro2+ influx and eventually leads to end-stage pyroptotic cell lysis.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Gsdmd is required for caspase-1 induction of both the prelytic pyroptotic pores and the subsequent pyroptotic lysis. (A) The gRNAs used to generate CRISPR-Cas9 Gsdmd−/− iBMDMs. (B) Gsdmd was immunoprecipitated from untreated WT NTG, Gsdmd−/− Guide 1 (G1: four pooled clones), and Gsdmd−/− Guide 2 (G2: two pooled clones) iBMDM whole cell lysates were incubated overnight with anti–GSDMDC-1 and then with protein G-Sepharose. Immunoprecipitated samples were probed for Gsdmd and IgG H chain, and soluble cell lysates were probed for actin. These data are representative of results from one experiment. (C) LPS-primed WT iBMDMs in the presence or absence of 50 μM of zVAD and LPS-primed NTG, Gsdmd−/− Guide 1 (Gsdmd−/− G1), and Gsdmd−/− Guide 2 (Gsdmd−/− G2) were stimulated with NG (10 μM) for 45 min, and Pro2+ fluorescence was quantified every 3 min as described in Fig. 1. These data represent the mean ± SE of four replicates from two independent experiments. (D) LPS-primed WT, Gsdmd−/− G1, and Gsdmd−/− G2 iBMDMs were stimulated with NG for 30 and 60 min, and the supernatants were subsequently assayed for LDH activity as described in Fig. 1. These data represent the mean ± SE of four replicates from two independent experiments. ***p < 0.001, *p < 0.05. (E) Gsdmd−/− G1 iBMDMs were stimulated with NG (10 μM) for 2 or 3 h, and Pro2+ or YoPro2+ fluorescence was quantified every 3 min as described in Fig. 1. Where indicated, the assay medium was supplemented with 50 μM of zVAD-fmk, 50 μM of zDEVD-fmk, or 30 μM of trovafloxacin. These data represent the mean ± SE of four replicates from two independent experiments.

During prolonged NLRP3 inflammasome activation in the absence of Gsdmd, macrophages eventually divert to apoptosis (16). Apoptotic caspase-7 is a substrate of caspase-1 (46) and, in the absence of Gsdmd, macrophages accumulated cleaved caspase-3/7 and active caspase-8 within several hours after assembly of caspase-1 inflammasomes. He et al. (16) also reported that Gsdmd-null macrophages accumulated nuclear Pro2+ after 3 h of NG stimulation. The dye accumulation in the Gsdmd-deficient cells may reflect lytic uptake caused by secondary necrosis and/or prelytic influx through other large-pore ion channels, such as pannexin-1 (Panx1). Núñez and colleagues (47) recently described an alternative pyroptotic pathway initiated by caspase-11–dependent cleavage of Panx1 channels in murine macrophages. We used NG-stimulated Gsdmd-deficient iBMDMs to define alternative modes by which accumulation of active caspase-1 can alter PM permeability. After an ∼60-min delay, the cells began to accumulate Pro2+, and this response was completely suppressed by the pan-caspase inhibitor zVAD or caspase-3–selective inhibitor DEVD, but not the Panx1 blocker trovafloxacin (Fig. 3E). Activated Panx1 channels have low permeability to Pro2+ but high permeability to YoPro2+, which has the same charge but smaller mass (375 Da) compared with Pro2+ (Supplemental Table I) (27, 48–50). In response to NG, Gsdmd-null iBMDMs displayed a delayed and zVAD-sensitive increase in YoPro2+ accumulation (Fig. 3E). Notably, trovafloxacin produced a 2-fold decrease in the rate of YoPro2+ uptake. This suggests that caspase-3/7–gated Panx1 channels contribute to the altered PM permeability of inflammasome-activated macrophages under conditions of suppressed pyroptosis.

Lanthanides coordinately suppress both the caspase-1–dependent PM permeability change and pyroptotic lysis induced by NLRP3 and Pyrin inflammasome activation

To further characterize the molecular and biophysical properties of the caspase-1/Gsdmd–induced pore and its mechanistic coupling to pyroptotic cell death, we investigated whether the pore could be targeted pharmacologically. Given its nonselective permeability to large organic and inorganic cations and anions, we tested whether activity of the pyroptotic pore might be blocked by lanthanides (Gd3+ and La3+), which are broadly acting channel inhibitors. Lanthanides are known to inhibit nonselective cation channels (51) and a broad range of large-pore channels (52). WT BMDMs stimulated with NG in the presence of 1 mM of Gd3+ or La3+ were characterized by modest decreases in the rate of Pro2+ influx relative to that observed in lanthanide-free medium (Fig. 4A, 4B). The rate and magnitude of suppression was much greater as the lanthanide concentration increased to 1.2 mM (Gd3+: ∼60% mean suppression, La3+: 100%) and 1.5 mM (Gd3+: ∼90% mean suppression, La3+: 100%) (Fig. 4A, 4B). Thus, the inhibitory effects of lanthanides on pyroptosis-induced PM permeabilization were defined by very steep concentration–response relationships with La3+ as a modestly more potent suppressor compared with Gd3+. We verified that the lanthanides similarly suppressed the pyroptotic PM permeability change induced by pyrin inflammasomes. In these experiments, the BMDMs were treated with increasing concentrations of Gd3+ or La3+ added 20 min post-TcdB, which is after the toxin has been internalized but before initiation of Pro2+ influx. A total of 1 mM Gd3+ or La3+ induced a marked suppression in the rate and magnitude of Pro2+ influx (Gd3+: ∼30% mean suppression, La3+: ∼60% mean suppression) (Fig. 4C, 4D). The efficacy of blockade was increased as the concentrations were increased to 1.2 mM (Gd3+: ∼60% mean suppression, La3+: ∼70% mean suppression) and 1.5 mM (Gd3+: ∼90% mean suppression, La3+: ∼90% mean suppression) (Fig. 4C, 4D). These results demonstrate that the lanthanides suppress pyroptotic Pro2+ influx downstream of two distinct inflammasome signaling pathways.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Lanthanides coordinately suppress both the caspase-1–dependent PM permeability change and pyroptotic lysis induced by NLRP3 and Pyrin inflammasome activation. (A) LPS-primed WT BMDMs were stimulated with NG (10 μM) in the presence or absence of Gd3+ (1, 1.2, and 1.5 mM) or (B) La3+ (1, 1.2, 1.5 mM) for 45 min, and Pro2+ fluorescence was quantified every 3 min as described in Fig. 1. These data represent the mean ± SE of four replicates from two independent experiments. (C) LPS-primed WT BMDMs were stimulated with TcdB (0.4 μg/ml) in the presence or absence of Gd3+ (1, 1.2, and 1.5 mM) or (D) La3+ (1, 1.2, 1.5 mM) for 60 min, and Pro2+ fluorescence was quantified every 4 min. Gd3+ and La3+ were added 20 min after TcdB (after the toxin has been internalized but before pyroptotic Pro2+ influx). These data represent the mean ± SE of two to eight replicates from six independent experiments. (E) LPS-primed WT BMDMs were stimulated with NG for 30 min in the presence or absence of 1.2 mM of Gd3+ or La3+, and the supernatants were subsequently assayed for LDH activity as described in Fig. 1. These data represent the mean ± SE of four replicates from two independent experiments. (F) LPS-primed WT BMDMs were stimulated with TcdB for 45 min in the presence or absence of 1 mM of Gd3+ or La3+, and the supernatants were subsequently assayed for LDH activity. Gd3+ and La3+ were added 20 min after TcdB. These data represent the mean ± SE of four replicates from two independent experiments. (G) LPS-primed WT BMDMs were stimulated as in (E). Pro2+ fluorescence was quantified 30 min post-NG. These data represent the mean ± SE of four replicates from two independent experiments. (H) LPS-primed WT BMDMs were stimulated as in (F). Pro2+ fluorescence was quantified 45 min post-TcdB. These data represent the mean ± SE of eight replicates from six independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.

We next determined whether the lanthanides also suppress the downstream execution of pyroptotic cell death by assaying LDH release as an indicator of lysis. WT BMDMs stimulated with NG for 30 min (a time point corresponding to active pyroptotic Pro2+ influx) in the presence of 1.2 of mM Gd3+ or La3+ released markedly less LDH compared with cells stimulated with NG in lanthanide-free medium (Fig. 4E). In the presence of 1.2 of mM Gd3+ or La3+, the percent suppression of LDH release (Gd3+: 67% mean suppression, La3+: 86% mean suppression) was comparable with the percent suppression of NG-induced Pro2+ influx (Gd3+: 70% mean suppression, La3+: 99% mean suppression) over 30-min test periods (Fig. 4E, 4G). Pyroptotic cell death induced by TcdB-stimulated pyrin inflammasome activation was similarly attenuated by the lanthanides (Fig. 4F, 4H). In the presence of 1 mM of Gd3+ or La3+, the percent suppression of LDH release (Gd3+: 48% mean suppression, La3+: 58% mean suppression) was comparable with the percent suppression of Pro2+ influx (Gd3+: 45% mean suppression, La3+: 71% mean suppression) (Fig. 4F, 4H). Taken together, these data demonstrate that, similar to the phenotype of Gsdmd-deficient macrophages, inflammasome-activated WT BMDMs are characterized by a profound suppression in both caspase-1–mediated PM permeabilization and downstream pyroptotic cell lysis in the presence of lanthanides.

Lanthanides have previously been used to probe inflammatory signaling responses in other inflammasome models. Yang et al. (47) found that Gd3+ did not suppress LDH release in their model of caspase-11/Panx1–mediated pyroptosis. However, that study tested only 100 μM of Gd3+, a concentration that was also submaximal for blocking Pro2+ influx and LDH release in our model of caspase-1/Gsdmd–mediated pyroptosis (Supplemental Figs. 1, 3). Compan et al. (53) used 2 mM of Gd3+ or 2 mM of La3+ to block IL-1β release and YoPro2+ uptake in response to hypotonicity-stimulated NLRP3 inflammasome activation. In that model, the lanthanides were used to block activity of the TRPM7 and TRPV2 ion channels, which functioned as upstream regulators of the volume-sensitive caspase-1 activation response. This contrasts with our use of the lanthanides to block downstream responses to caspase-1 activation by canonical inflammasome stimuli. Lee et al. (54) used 1 mM of extracellular Gd3+ as an agonist for the G protein–coupled calcium-sensing receptor that was linked to NLRP3 inflammasome activation. In contrast, we observed no stimulatory effects of the lanthanides per se on pyroptotic signaling or inflammasome activation when added alone in the absence of NG (data not shown). A caveat in interpretation of the Lee et al. finding is that the Gd3+ was added to phosphate-containing medium, which can result in formation of insoluble gadolinium phosphate particles, phagocytosis of the particles, and subsequent lysosome destabilization, a known NLRP3 activation stimulus (31).

Interestingly, there was an escape from lanthanide suppression of lytic LDH release as the duration of NLRP3 or pyrin inflammasome stimulation was prolonged (Supplemental Fig. 2A–C). Also, there was a more rapid escape from pyroptotic suppression in the presence of 1 versus 1.2 mM concentrations of Gd3+ or La3+ during NG stimulation (Supplemental Fig. 2A, 2B). This suggests either a time-dependent loss in efficacy of lanthanide suppression and/or that signaling events downstream of caspase-1/Gsdmd target the integrity of intracellular organelle compartments, as well as the PM to facilitate the execution of pyroptotic cell death.

In contrast with the escape from lanthanide suppression of LDH release with longer duration (60 min) NG stimulation in WT BMDMs (Supplemental Fig. 2A, 2B), Gsdmd−/− C1 and Gsdmd−/− C2 iBMDMs maintained complete suppression of LDH release at 60 min post-NG stimulation (Fig. 3D). Sustained suppression of lytic death in the absence of Gsdmd further suggests that, in addition to PM pyroptotic pore induction, Gsdmd may target other intracellular signaling responses that contribute to the pyroptotic cell death process.

We verified that lanthanides attenuate caspase-1–dependent pyroptotic signaling in iBMDMs similarly to their actions in primary BMDMs. As in primary WT BMDMs, concentrations of Gd3+ or La3+ >1 mM markedly attenuated Pro2+ influx in WT iBMDMs in response to NG (Supplemental Fig. 1B, 1C). Likewise, 1.2 mM of Gd3+ or La3+ suppressed downstream lytic LDH release at 30 min post-NG stimulation in WT iBMDMs (Supplemental Fig. 1D). However, at 60 min after NG stimulation, WT iBMDMs exhibited an escape from lanthanide suppression of LDH release similarly to primary WT BMDMs (Supplemental Fig. 1D).

Lanthanides do not block NLRP3 inflammasome activation or IL-1β release, whereas Gsdmd deficiency also does not block NLRP3 inflammasome activation but does block IL-1β release

To test whether the lanthanides might suppress downstream pyroptotic signaling by inhibiting upstream inflammasome assembly or activity, we assayed various indices of inflammasome activation in response to NG (Fig. 5) or TcdB (Supplemental Fig. 2D) stimulation in the presence of Gd3+ or La3+. After 30 min of NG stimulation in the presence of 1, 1.2, and 1.5 mM of Gd3+ or La3+ (concentrations that suppress pyroptotic Pro2+ influx in a dose-dependent manner), WT BMDMs displayed intact ASC oligomerization (Fig. 5A), suggesting the assembly of an ASC-containing inflammasome complex. Control experiments (data not shown) indicated that treatment of the BMDMs with lanthanides alone produced no stimulatory or inhibitory effects on ASC oligomerization, caspase-1 activation, or IL-1β release.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Lanthanides do not block NLRP3 inflammasome activation or IL-1β release, whereas Gsdmd deficiency also does not block NLRP3 inflammasome activation but does block IL-1β release. (A) LPS-primed WT BMDMs were stimulated with NG (10 μM) for 30 min in the presence or absence of Gd3+ or La3+ (0.3, 1, 1.2, and 1.5 mM). The ECM and soluble cell lysates were processed and analyzed on Western blot for the presence of caspase-1 and IL-1β. The detergent insoluble fraction was DSS cross-linked and analyzed on Western blot for the presence of oligomerized ASC. Western blot analysis of the soluble lysate for actin was also performed. These data are representative of results from two experiments. (B) LPS-primed WT BMDMs were treated as in (A) in the presence of 5 mM of glycine. The ECM, soluble lysate, and detergent insoluble fraction were analyzed on Western blot as described in (A). These data are representative of results from two separate experiments. (C) LPS-primed WT, Gsdmd−/− G1 (G1), and Gsdmd−/− G2 (G2) iBMDMs were stimulated with NG for 30 min. The ECM and soluble lysates were processed and analyzed on Western blot for the presence of caspase-1 and IL-1β. Western blot analysis of the soluble lysate for Gsdmd and actin was also performed. The detergent insoluble fraction of the cell lysates was incubated with the chemical cross-linker DSS and analyzed on Western blot for the presence of ASC monomers, dimers, and oligomers. These data are representative of results from two experiments. Asterisk represents nonspecific band.

Increasing concentrations of Gd3+ or La3+ resulted in an enhanced retention of processed caspase-1 in the cell lysate during 30-min incubations with NG (Fig. 5A). The production of processed caspase-1 in the presence of Gd3+ and La3+ further demonstrated that the lanthanides do not limit NLRP3 inflammasome complex assembly and downstream caspase-1 activation. Notably, at the 1, 1.2, and 1.5 mM concentrations of Gd3+ or La3+, procaspase-1 was predominantly retained in the cell lysate, whereas in the absence of Gd3+ and La3+ (or at the 300 μM concentration that does not suppress pyroptosis), some procaspase-1 was released into the ECM (Fig. 5A).

We also examined the effect of lanthanide treatment on the extent of mature IL-1β production as an additional index of inflammasome activation. Western blot analysis revealed that WT BMDMs, stimulated with NG for 30 min in the presence of concentrations (>1 mM) of Gd3+ and La3+ that inhibit pyroptotic dye uptake, generated and released mature IL-1β in amounts comparable with that observed in the absence of lanthanides (Fig. 5A). This marked production of mature IL-1β in the presence of Gd3+ and La3+ further demonstrates that the lanthanides do not limit NLRP3 inflammasome activation. Importantly, the additional presence of glycine to attenuate cell lysis did not modulate the effects of the lanthanides on NG-stimulated NLRP3 inflammasome signaling and IL-1β export (Fig. 5B).

The inhibitory effects of lanthanides on pyroptotic signaling responses downstream of inflammasome activation mostly mimicked the effects of Gsdmd knockout with the following notable exception: release of caspase-1 processed mature IL-1β to the extracellular compartment. We confirmed previous findings (16) that Gsdmd deficiency does not limit upstream inflammasome activation in response to NG. WT, Gsdmd−/− G1, and Gsdmd−/− G2 iBMDMs were stimulated with NG for 30 min, and the formation of mature caspase-1 and IL-1β and the oligomerization of ASC were assayed by Western blot. The cell lysates of unstimulated WT iBMDMs, but not the Gsdmd−/− cells, contained full-length 53 kDa Gsdmd that was extensively processed to the 31-kDa N-terminal fragment after NG stimulation; this is consistent with previous reports that active caspase-1 cleaves Gsdmd to produce a 31-kDa N-terminal propyroptotic product (13, 14, 16). Both WT and Gsdmd−/− iBMDMs exhibited intact ASC oligomerization and robust accumulation of processed caspase-1 and IL-1β (Fig. 5C), indicating that Gsdmd mediates downstream pyroptosis but not upstream NLRP3 inflammasome activation.

Notably, mature IL-1β and caspase-1 were completely retained in the cell lysates of the Gsdmd−/− iBMDMs but were predominantly released into the ECM fraction of WT iBMDMs (Fig. 5C). Nonlytic IL-1β and caspase-1 release represented a major mode of export because comparable amounts of mature IL-1β and caspase-1 were present in the ECM fractions of WT iBMDMs in the presence or absence of glycine (Fig. 5C). Therefore, the absence of Gsdmd does not simply prevent release of caspase-1 and IL-1β as a consequence of blocked pyroptotic lysis, but also suppresses the nonlytic export of these cytosolic proteins that has been previously described in multiple models of inflammasome function (2, 3).

Whereas NG-stimulated Gsdmd−/− macrophages were characterized by intracellular retention of both mature IL-1β and the p20 subunit of active capase-1 (Fig. 5C), WT BMDMs treated with NG in the presence of lanthanides retained the active p20 caspase-1 in the cytosol but released mature IL-1β to the ECM. To clarify how the absence of Gsdmd, but not the presence of lanthanides, completely suppressed the release of IL-1β, we further investigated the effect of lanthanide treatment on caspase-1 and IL-1β export. Interestingly, concentrations of Gd3+ and La3+ that inhibit caspase-1–induced PM permeabilization (1, 1.2, 1.5 mM) also greatly suppressed caspase-1 release but permitted robust IL-1β release in response to 30 min of NG stimulation (Fig. 5A). Also, similar amounts of 20 kDa caspase-1 and mature IL-1β were present in the ECM fraction in the presence and absence of the cytoprotectant glycine, which prevents cell lysis (Fig. 5A, 5B). These data suggest that Gsdmd knockout per se and lanthanide blockade of the Gsdmd-dependent PM permeability change regulate nonlytic caspase-1 and IL-1β export in distinct ways. Lanthanide inhibition of Gsdmd-induced PM permeabilization markedly limits nonlytic caspase-1 release; however, it permits robust IL-1β release, which further underscores an apparent role for Gsdmd in the nonlytic vesicular trafficking and export of IL-1β.

Similarly, after 45 min of TcdB stimulation in the presence of 1 mM of Gd3+ or La3+ (concentrations that suppress pyroptotic Pro2+ influx), WT BMDMs also displayed intact ASC oligomerization and caspase-1 activation (Supplemental Fig. 3). Although the presence of 1 mM of Gd3+ or La3+ did not prevent the formation of processed caspase-1, the p20 fragment of caspase-1 and procaspase-1 were retained in the cell lysate. Taken together, these data demonstrate that Gd3+ and La3+ do not suppress NLRP3 and Pyrin inflammasome activation or caspase-1 activity, but rather inhibit the downstream pyroptotic signaling processes.

Lanthanides reversibly block the caspase-1–dependent pyroptotic pores and suppress pyroptosis

Given that Gd3+ and La3+ inhibit caspase-1–dependent PM permeabilization without limiting inflammasome activation, we next investigated the mechanism by which lanthanides target this PM permeability change. Because there is a narrow time window between pyroptotic pore opening and subsequent lysis, we first verified that lanthanides suppress prelytic pyroptotic Pro2+ influx before end-stage lysis by stimulating WT BMDMs with NG in the presence of glycine ± 1.5 mM of Gd3+ or 1.2 mM of La3+. A total of 1.5 mM of Gd3+ and 1.2 mM of La3+ almost completely suppressed pyroptotic Pro2+ influx in the presence of glycine, similar to the responses in the absence of glycine (Fig. 6A, 6B). Interestingly, the lanthanides were more potent as suppressors of pyroptosis-induced Pro2+ influx in the presence of glycine than in its absence (Supplemental Fig. 3A–D). For example, 800 μM of Gd3+ and La3+ partially suppressed the rate and magnitude of NG-induced Pro2+ influx in the presence of glycine, but not in the absence of glycine (Supplemental Fig. 3E, 3F). Also, 1 mM of Gd3+ and La3+ was more efficacious in reducing the rate and magnitude of NG-induced Pro2+ influx in the presence of glycine versus in its absence (Supplemental Fig. 3G, 3H). Together these data indicate that lanthanides target the prelytic PM permeability change induced by upstream caspase-1/Gsdmd signaling that may include: 1) gating of large-pore channels already resident in the PM, or 2) insertion of pore-forming proteins into the PM.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Lanthanides reversibly block the caspase-1–dependent pyroptotic pores and suppress pyroptosis. (A) LPS-primed WT BMDMs were stimulated with NG (10 μM) in the presence or absence of 5 mM of glycine and ± 1.5 mM of Gd3+ or (B) 1.2 mM of La3+ for 45 min, and Pro2+ fluorescence was quantified every 3 min as described in Fig. 1. These data represent the mean ± SE of four to six replicates from two to three independent experiments. (C) LPS-primed WT BMDMs were stimulated with NG in the presence or absence of 1.5 mM of Gd3+ or (D) 1.2 mM of La3+ for 45 min. At 15 min post-NG stimulation, wells containing WT BMDMs, Pro2+, NG, and Gd3+/La3+ were either washed with PBS (+W) and replaced with fresh NaCl BSS plus 1 μg/ml Pro2+ or not washed (−W). Pro2+ fluorescence was quantified every 3 min. These data represent the mean ± SE of four to six replicates from two to three independent experiments. (E) LPS-primed WT BMDMs were stimulated with NG in the presence or absence of 1.5 mM of Gd3+ or (F) 1.2 mM of La3+ for 45 min. Pro2+ and lanthanides (Gd3+ or La3+) were added at different times during NLRP3 inflammasome activation, which included: 1) Pro2+ and lanthanides added at the same time as NG (T = 0; blue curve); 2) Pro2+ added at the same time as NG, and lanthanides added 20 min post-NG (T = 20; green curve); or 3) lanthanides added 20 min post-NG, and Pro2+ added 5 min postlanthanide addition (T = 20*; magenta curve). Pro2+ fluorescence was quantified every 3 min. These data represent the mean ± SE of four to six replicates from three (E) or two (F) separate experiments. (G) LPS-primed WT BMDMs were stimulated with TcdB in the presence or absence of 1.5 mM of Gd3+ or (H) La3+ for 60 min. Pro2+ and lanthanides were added at different times during Pyrin inflammasome activation, which included: 1) Pro2+ added at the same time as TcdB, and lanthanides added 20 min post-TcdB (T = 20; blue curve); 2) Pro2+ added at the same time as TcdB, and lanthanides added 30 min post-TcdB (T = 30; green curve); or 3) lanthanides added 30 min post-TcdB, and Pro2+ added 5 min postlanthanide addition (T = 30*; magenta curve). Pro2+ fluorescence was quantified every 4 min. These data represent the mean ± SE of two to eight replicates from two independent experiments.

Previous studies have demonstrated that lanthanides can inhibit channels by either acting as competitive pore blockers (55–57) or binding to anionic phospholipids to induce lateral compression of channels (58, 59). Lanthanides have similar cationic radii as Ca2+, enabling them to compete for binding within the selectivity filter of Ca2+ channels (55–57). Sukharev and colleagues (58) have reported that Gd3+ reversibly inhibits the large mechanosensitive channel of E. coli by binding to anionic phospholipids. Gd3+ binding then alters phospholipid packing and greatly increases the lateral pressure within the PM, which forces the large mechanosensitive channel to adopt a closed conformation (58).

We designed experiments to determine whether the lanthanides reversibly inhibit the pyroptotic pore/channel. After stimulating WT BMDMs for 15 min with NG in the presence of Pro2+ and 1.5 mM of Gd3+ or 1.2 mM of La3+, the lanthanide-containing ECM were removed and replaced with fresh Pro2+-containing media. The removal of Gd3+ and La3+ rapidly restored the NG-induced Pro2+ influx (Fig. 6C, 6D), suggesting that lanthanides reversibly block the Gsdmd-dependent pyroptotic pore/channel.

Next, Gd3+/La3+ and Pro2+ were added at different times during the course of NLRP3 or Pyrin inflammasome activation to investigate whether lanthanides inhibit the presumed assembly/activation of the pyroptotic pore or the flux of permeant ions through an already assembled/activated pore. When 1.5 mM of Gd3+ or 1.2 mM of La3+ was added to WT BMDMs during NG-induced pyroptotic Pro2+ influx (T = 20; 20 min post-NG), further dye uptake was prevented (Fig. 6E, 6F). Similarly, adding 1.5 mM of Gd3+ or La3+ to WT BMDMs during TcdB-induced pyroptotic Pro2+ influx (T = 30; 30 min post-TcdB) prevented further dye uptake (Fig. 6G, 6H). Also, if 1.5 mM of Gd3+ or 1.2 mM of La3+ was added after NG-induced pyroptotic pore opening (20 min post-NG) and Pro2+ was added 5 min later (T = 20*; Pro2+ added 5 min postlanthanide addition), dye uptake was almost completely suppressed (Fig. 6E, 6F). Similarly, adding 1.5 mM of Gd3+ or La3+ after TcdB-induced pyroptotic pore opening (30 min post-TcdB) and then adding Pro2+ 5 min later (T = 30*; Pro2+ added 5 min postlanthanide addition) also almost completely suppressed dye uptake (Fig. 6G, 6H). Residual dye uptake could reflect BMDMs that have already progressed to lytic cell death. Because Gd3+ and La3+ prevented further pyroptotic dye uptake and almost completely prevented any pyroptotic dye uptake if Pro2+ was added after Gd3+ and La3+, direct pore blockade and/or lateral compression of a pore/channel are plausible mechanisms for how lanthanides reversibly inhibit activity of the pyroptotic pore/channel. Using the lanthanides as a tool to characterize the nature of the caspase-1–dependent PM permeability change suggests that Gd3+ and La3+ may reversibly inhibit an already active Gsdmd-containing pore or pyroptotic pore/channel(s) regulated by Gsdmd.

Panx1, P2X7R, and certain TRP channel family members are not required for caspase-1–dependent pyroptotic pore induction

Given the observed permeability characteristics and lanthanide sensitivity of the pyroptotic pore/channels, we investigated the potential role of known large-pore channels in mediating caspase-1–dependent pyroptosis. For example, Panx1 is an important ATP release channel that adopts a large-pore conformation upon activation and is also permeable to large DNA-intercalating fluorescent dyes (52, 60). Interestingly, Panx1 channels can be gated by apoptotic executioner caspases that excise an autoinhibitory domain from the Panx1 cytosolic C terminus (60). Núñez and colleagues (47) recently reported that Panx1 is also cleaved by caspase-11 to mediate caspase-11–dependent pyroptosis in macrophages that accumulate cytosolic LPS. However, we found that the Panx1 inhibitor trovafloxacin did not suppress NG-induced pyroptotic Pro2+ influx in WT BMDMs (Fig. 7A), suggesting that Panx1 is not required for caspase-1/Gsdmd–dependent prelytic pore activation in the context of canonical inflammasome-driven pyroptosis.

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

Panx1, P2X7R, and certain TRP channel family members are not required for caspase-1–dependent pyroptotic pore induction. (A) LPS-primed WT BMDMs were stimulated with NG (10 μM) for 45 min in the presence or absence of the Panx1 inhibitor trovafloxacin (30 μM). These data represent the mean ± SE of four replicates from two independent experiments. (B) LPS-primed WT BMDMs were stimulated with NG for 45 min in the presence of the P2X7R antagonists A10606120 (10 μM) or A438079 (10 μM). These data represent the mean ± SE of four replicates from two independent experiments. (C) LPS-primed WT or P2X7R−/− BMDMs were stimulated with NG or (D) TcdB (0.4 μg/ml) for 45 min. These data represent the mean ± SE of three replicates from one experiment. (A–D) Pro2+ fluorescence was quantified every 3 (NG) or 4 (TcdB) min as described in Fig. 1. (E) LPS-primed WT or P2X7R−/− BMDMs were stimulated with NG. At the indicated times, supernatants were assayed for LDH activity as described in Fig. 1. These data represent the mean ± SE of two replicates from one experiment. (F) LPS-primed WT BMDMs were stimulated with NG for 45 min or (G) TcdB for 60 min in the presence of the TRPV channel inhibitor ruthenium red (RR: 1 μM) or the TRPM7 channel inhibitor NS8593 (30 μM). These data represent the mean ± SE of two to four replicates from two (F) or one (G) independent experiment. (F and G) Pro2+ fluorescence was quantified every 3 (NG) or 4 (TcdB) min as described in Fig. 1.

P2X7R is an ATP-gated nonselective cation channel that can adopt a large-pore conformation that is both permeable to large DNA-intercalating fluorescent dyes and inhibited by Gd3+ (52). ATP gating of the P2X7R also mediates NLRP3 inflammasome activation by facilitating K+ efflux (30, 31, 61). Autocrine activation of P2X7R by ATP released through Panx1 channels has also been implicated in mediating caspase-11–dependent pyroptosis (47). However, we found that the P2X7R antagonists A10606120 and A439079 did not suppress NG-induced Pro2+ influx in WT BMDMs (Fig. 7B). Similarly, P2rx7−/− BMDMs stimulated with NG or TcdB exhibited comparable rates and magnitudes of Pro2+ influx with those observed in WT BMDMs (Fig. 7C, 7D). Consistent with this, the absence of P2X7R did not suppress downstream LDH release in response to NG (Fig. 7E). These data suggest that the P2X7R is also not required for the caspase-1– and Gsdmd-dependent prelytic pore induction or ensuing pyroptotic lysis downstream of canonical inflammasomes.

We also evaluated the roles of certain members of the TRP channel family, which are nonselective ion channels in mediating caspase-1/Gsdmd–induced pyroptosis given their expression in hematopoietic cells, sensitivity to lanthanides, activation by multiple cell stressors, and roles in innate immunity (51). Specifically, TRPV2 and TRPM7 have been implicated in NLRP3 inflammasome activation in response to hypotonic stress (53). TRPM7 can also be proteolytically gated by apoptotic caspases and is involved in Fas-induced apoptosis (62). TRPM2 is gated in response to oxidative stress (63), and mitochondrial reactive oxygen species (ROS) production has been implicated in NLRP3 inflammasome activation (64). In particular, mitochondrial ROS–dependent TRPM2 activation was shown to mediate liposome/particulate-induced NLRP3 inflammasome activation (65). We observed that neither the broad TRP channel inhibitor ruthenium red nor the selective TRPM7 inhibitor NS8593 (66, 67) suppressed NG- or TcdB-induced pyroptotic Pro2+ uptake (Fig. 7F, 7G). In another recent study (68), we reported that Trpm2−/− BMDCs stimulated with NG did not exhibit reduced Pro2+ influx compared with that in WT cells. Taken together, these experiments indicate that TRPV, TRPM7, or TRPM2 channels are not required components of the caspase-1/Gsdmd–dependent pyroptotic pores.

Discussion

The identity of the caspase-1/11–induced pyroptotic pore/channel(s) remains an elusive component of the pyroptotic cell death signaling cascade. Our findings provide new and mechanistically significant insights regarding the nature of this caspase-1–mediated PM permeability change. We have shown that caspase-1–dependent pyroptosis requires an initial nonlytic permeabilization of the PM that involves the opening of a large, nonselective cation- and anion-permeable pore/channel(s). Pyroptotic pore activation requires Gsdmd, and the activity of the pores can be reversibly inhibited by lanthanides. Furthermore, lanthanide suppression of the caspase-1– and Gsdmd-dependent PM pore/channel has uncovered potential roles for Gsdmd at other intracellular compartments to facilitate pyroptotic cell death and modulate nonclassical vesicular trafficking and export of IL-1β.

Recent studies have demonstrated that the cleaved N terminus of Gsdmd is required for end-stage pyroptotic cell lysis (13, 14, 16). We have shown that Gsdmd is not only necessary for the execution of pyroptotic cell death but is also required for upstream pyroptotic pore induction because pyroptotic Pro2+ uptake does not occur in the absence of Gsdmd (Fig. 3C). Possible mechanisms by which cleaved Gsdmd may induce the pyroptotic pore include: 1) Gsdmd forms the pore, 2) Gsdmd functions as a chaperone that enables the effective insertion of the pore into the PM, or 3) Gsdmd directly or indirectly regulates the gating of a pyroptotic channel(s).

Activated caspase-1/11 cleaves cytosolic Gsdmd, which relieves the autoinhibitory interaction between the N and C termini such that the N terminus can execute pyroptotic cell death (13, 14, 16). Necroptosis, a caspase-1/11–independent mode of inflammatory lytic cell death, involves RIP3-mediated phosphorylation of the cytosolic protein mixed lineage kinase domain-like (MLKL). This drives MLKL oligomerization and insertion into the PM to execute necroptotic cell death (69–71). Phosphorylation of the MLKL C terminus enables its dissociation from the N-terminal helical protein core, freeing the N terminus to oligomerize with other MLKL subunits and to insert into the PM to form a death pore (72). This relief of an intramolecular interaction between the C and N termini of MLKL so that the N terminus can serve a death executioner function may be analogous to the possible mechanism(s) underlying Gsdmd-mediated cell death. In such a model, cleaved Gsdmd N-terminal fragments may similarly oligomerize and form pyroptotic pores to execute lytic cell death. Future studies are necessary to address whether Gsdmd forms oligomers, localizes to the PM, and can bind membrane lipids. If oligomers of Gsdmd form the pyroptotic pores, it is possible that the pore size could vary under different conditions. Such a scenario might explain the differential rates of Pro2+ versus EthD4+ dye uptake in response to stimulation with TcdB versus NG (Fig. 2A, 2B). Another similarity between the PM permeability changes induced by necroptosis and pyroptosis is that La3+ also suppresses necroptotic Pro2+ accumulation (69). Therefore, lanthanides may function to broadly inhibit large oligomerized protein pores, such as MLKL during necroptotic signaling and, possibly, Gsdmd-containing pores during pyroptotic signaling.

We used the lanthanides Gd3+ and La3+ as reagents to characterize the caspase-1/Gsdmd–dependent change in PM permeability. Gd3+ and La3+ are known to broadly target large-pore, nonselective cation-permeable channels (51, 52). Because lanthanides have similar cationic radii as Ca2+, they competitively block the selectivity filter of Ca2+ channels (55–57). Gd3+ can reversibly inhibit mechanosensitive bacterial channels (58) by a mechanism that involves binding to anionic phospholipid head groups to exert lateral compression on the channels and thereby result in a closed-pore conformational state (58). We found that millimolar concentrations of lanthanides rapidly and reversibly inhibit the nonlytic, pyroptosis-induced Pro2+ influx (Fig. 6A–D). The presence of glycine also enhanced the potency of lanthanides as suppressors of pyroptotic Pro2+ uptake (Supplemental Fig. 3A–D); this could reflect a selective blocking effect of extracellular lanthanides on activity of the PM pyroptotic pore but not intracellular signaling processes that also contribute to pyroptotic lysis. In the absence of glycine, a higher concentration of Gd3+ and La3+ is required to effectively inhibit Pro2+ influx and corresponding downstream lysis. If pyroptotic Pro2+ uptake has already been initiated, La3+ and Gd3+ act to prevent further dye uptake; lanthanides also completely block influx of dye added after assembly/activation of the PM pore (Fig. 6E–H). Taken together, these pharmacologic studies suggest a model of the pyroptotic pore as either an inserted pore-forming protein or a PM resident channel that is gated by accumulation of cleaved Gsdmd. The data further suggest that lanthanides act either to directly block or to laterally compress the pore to a closed conformation upon binding to anionic phospholipid head groups.

Other than functioning as a direct pore-forming protein, Gsdmd may be involved in regulating intrinsic PM proteins that act as pyroptotic pore/channel(s). Núñez and colleagues (47) recently identified P2X7R and Panx1 as important mediators of caspase-11 dependent pyroptosis. They showed that intracellular LPS-induced activation of noncanonical inflammasome signaling involved caspase-11–dependent Panx1 cleavage that enabled both K+ efflux and ATP release (47). K+ efflux subsequently triggered NLRP3 inflammasome activation and caspase-1–dependent IL-1β processing and release (47). Autocrine P2X7R activation by the released ATP was required to mediate caspase-11–dependent pyroptosis because LDH release was suppressed in the absence of P2X7R expression or the presence of P2X7R antagonists (47). However, in our model of caspase-1–dependent pyroptosis, the absence of P2X7R, the presence of P2X7R antagonists, or the presence of trovafloxacin (a selective Panx1 inhibitor) did not suppress pyroptotic Pro2+ uptake (Fig. 7A–D). Because the absence of P2X7R also did not prevent downstream LDH release (Fig. 7E), these data indicate that neither P2X7R nor Panx1 is an obligatory component of the caspase-1/Gsdmd–mediated pyroptotic cascade. Given that Gsdmd is a substrate of caspase-11 and necessary for caspase-11–mediated pyroptosis (13, 14), future studies should investigate whether Gsdmd regulates Panx1 and/or P2X7R activation as part of the caspase-11–triggered noncanonical inflammasome pathway. Dixit and colleagues (14) demonstrated that caspase-1 activation and processing of IL-1β downstream of noncanonical inflammasome activation depend on Gsdmd, suggesting that Gsdmd may regulate or mediate the Panx1-dependent K+ efflux that drives NLRP3 inflammasome activation secondary to LPS-induced caspase-11 activation.

We investigated TRPM2, TRPV2, and TRPM7 as potential pyroptotic channel candidates because of their known sensitivity to lanthanides and their reported links to NLRP3 inflammasome regulation (53, 65). In addition, TRPM7 can be proteolytically gated by apoptotic caspases (62). However, we found no critical roles for any of these TRP-family channels in pyroptotic pore function based on either genetic or pharmacologic approaches (Fig. 7F, 7G). However, TRP channels comprise a large superfamily of nonselective cation channels with 27 members in humans. Therefore, a presently untested TRP-family channel may be involved in pyroptosis.

Members of the CALHM channel family represent other plausible pyroptotic channel candidates given the known function of CALHM1 as a large-pore channel. The CALHM family includes six human homologs. CALHM1 is a voltage-sensitive channel that is responsive to the removal of extracellular calcium and implicated in cortical neuronal excitability (73). It is a nonselective cation- and anion-permeable, large-pore channel with a diameter of 14 Å (1.4 nm) (74), which is similar to the estimated size range of the pyroptotic pore. It is also sensitive to Gd3+ and is an important ATP-release channel that is involved in taste perception (75).

In addition to the role of Gsdmd in mediating the permeability change at the PM, our experiments suggest that it may also regulate intracellular functions that contribute to pyroptotic cell lysis. Although lanthanides markedly delayed pyroptotic lysis of WT BMDMs and iBMDMs, the cells slowly progressed to lytic collapse with prolonged (60 min) NG-stimulated NLRP3 inflammasome signaling despite complete blockade of ionic flux through the PM pore (Supplemental Figs. 1, 2). In contrast, Gsdmd−/− iBMDMs did not exhibit escape from suppression of lytic LDH release during similar prolonged NG stimulation (Fig. 3D). After >2 h of stimulation, Gsdmd−/− iBMDMs increasingly progress to apoptosis and then secondary necrosis (Fig. 3E). This difference between the effects of Gsdmd knockout and lanthanide blockade of the pyroptotic pore on the rate of pyroptotic lysis indicates multiple roles for Gsdmd in integrating pyroptotic signaling downstream of inflammasome activation. Another member of the Gsdm family Gsdma3 has been shown to facilitate mitochondria-dependent cell death (76). Gain-of-function mutations in the C terminus of Gsdma3 relieve its autoinhibitory interaction with the N terminus (76). The N-terminal–exposed Gsdma3 is recruited to mitochondria to mediate mitochondrial permeability transition and ROS production, which disrupts mitochondrial ATP production and drives cell death (76). It is relevant to note that activation of NLRP3 or AIM2 inflammasomes leads to similar caspase-1–dependent mitochondrial damage (increased ROS production and dissipation of mitochondrial membrane potential) (77). Therefore, cleaved Gsdmd may associate with mitochondria, similar to activated Gsdma3, which disrupts mitochondrial homeostasis and accelerates cell death. Phosphorylated MLKL, which accumulates during the execution of necroptotic lysis, also associates with intracellular organelles, like the mitochondria, lysosomes, and endoplasmic reticulum, in addition to the PM (70). If Gsdmd functions similarly to MLKL, it is possible that cleaved Gsdmd may localize to various organelles to perturb their homeostatic function and thereby modulate progression of pyroptotic cell death.

In contrast with lanthanides, which inhibit the PM pyroptotic pore but not the additional intracellular functions that may contribute to pyroptosis, glycine does not suppress the altered PM permeability to ions and large dyes (Figs. 1, 2) but does dramatically delay end-stage lytic pyroptotic cell death. In previous studies of maitotoxin-induced oncotic/necrotic cell death of endothelial cells, glycine was shown to permit nonlytic PM permeability increases to Ca2+ and cationic dyes, as well as extensive cell swelling, but to prevent end-stage lysis as assayed through LDH release or GFP loss (41). Because glycine did not suppress the prelytic PM permeability to Pro2+, EthD4+, Ca2+, or adenine nucleotides during inflammasome activation (Figs. 1, 2), but did prevent LDH release, our data suggest that glycine may preserve the functional integrity of intracellular organelles to greatly delay progression to end-stage pyroptotic lysis. Mootha and colleagues (78) demonstrated that rapidly proliferating cancer cells exhibited a high extent of glycine consumption. If enzymes involved in glycine biosynthesis were knocked down, the proliferative capacity of these cancer cells would decrease (78). They also demonstrated that glycine supports a high proliferative capacity of cancer cells by promoting synthesis of purine nucleotides, including ATP (78). During pyroptosis, the caspase-1– and Gsdmd-dependent PM permeabilization will disrupt normal ionic homeostasis and thereby place a large osmotic stress on macrophages. The resulting ionic and osmotic dysregulation will result in enhanced ATP-driven Na+/K+ pump activity, which, in turn, will place a large metabolic stress on the cell. Future studies should test whether the presence of glycine may sustain ATP synthesis and thereby preserve cellular energetics to delay end-stage pyroptotic cell lysis.

In addition to the role of Gsdmd in the execution of pyroptotic cell death, it was also critical for the release of mature caspase-1 and IL-1β into the extracellular environment, but not the intracellular processing of these proteins (Fig. 3E). Shao and colleagues (13) also observed that the absence of Gsdmd prevented IL-1β export without affecting its processing after canonical inflammasome activation. Gsdmd may be critical for IL-1β release as a secondary consequence of mediating end-stage pyroptotic lysis; however, our experiments with glycine, which preserves IL-1β and caspase-1 release whereas suppressing macrophage lysis (Fig. 5), suggest that Gsdmd may additionally regulate nonlytic IL-1β export. Potential modes of nonlytic release of IL-1β include secretory lysosome exocytosis, microvesicle shedding, multivesicular body formation and fusion with the PM to release exosomes, and autophagy (2, 3). Fink and Cookson (19) also suggested that direct IL-1β efflux via pyroptotic pores may represent a potential nonlytic release mechanism. We tested this possibility by assaying IL-1β and caspase-1 release in the presence of Gd3+ and La3+, which block ionic fluxes through the pyroptotic pore. At concentrations that inhibit pyroptotic pore function, lanthanides markedly suppressed the release of mature caspase-1, but not the export of IL-1β (Fig. 5). This suggests that IL-1β and caspase-1 are exported via distinct pathways. In an early investigation of IL-1β and caspase-1 export mechanisms, Kostura and colleagues (79) used electron microscopy of monocytes stimulated with heat-killed Staphylococcus aureus to show that immunogold-labeled precursor and processed caspase-1 and IL-1β decorated the external surface of the PM. This suggested that caspase-1 and IL-1β may associate with PM pores to facilitate their export. Taken together, our comparisons of how Gsdmd-knockout versus the presence of lanthanides or glycine differentially affect IL-1β and caspase-1 export suggest that Gsdmd regulates both nonlytic and lytic mechanisms of release of these inflammatory proteins. In terms of nonlytic export, Gsdmd-dependent pyroptotic pore formation may facilitate caspase-1 and IL-1β permeation through the pore. IL-1β may use additional Gsdmd-dependent vesicular trafficking mechanisms because robust IL-1β release is observed during pyroptotic pore inhibition by lanthanides, whereas the absence of Gsdmd greatly reduces IL-1β export. If cleaved Gsdmd traffics to intracellular organelles, such as mitochondria, to facilitate pyroptotic cell death, analogous to activated Gsdma3 recruitment to mitochondria (76), it is plausible that Gsdmd may also traffic to the recycling endosomal compartments implicated in noncanonical IL-1β release.

In summary, we have characterized the nature of the caspase-1–dependent PM permeability change as a lanthanide-sensitive, Gsdmd-dependent, nonselective pore or channel permeable to relatively large organic cations and anions. Gsdmd protein may either comprise the critical subunits of such pores or regulate other proteins that comprise the pyroptotic pores. Gsdmd also facilitates the nonlytic vesicular trafficking and release of IL-1β and may modulate the integrity of intracellular organelles that contribute to the execution of pyroptotic cell death. Whether Gsdmd specifically localizes at the PM and/or other intracellular organelles and how that impacts cellular function and execution of cell death remains to be defined.

Note added in proof.

Shortly after this paper was accepted, Shao and colleagues (80) reported that the N-terminal domain of gasdermin D (and other gasdermin family proteins) can directly associate with either native or artificial phospholipid membranes to form membrane pores.

Disclosures

The authors have no financial conflicts of interest.

Footnotes

  • This work was supported by National Institutes of Health (NIH) Grants R01-GM36387 (to G.R.D.), R01-EY014362 (to G.R.D.), R01-GM086550 (to D.W.A.), and P01-DK091222 (to D.W.A.); National Multiple Sclerosis Society Grant NMSS RG5130A2/1 (to G.R.D.); NIH Training Grants T32-AI089474 (to H.M.R.), T32-GM007250 (to H.M.R.), and T32-GM007250 (to J.R.); American Heart Association Predoctoral Fellowship 13PRE16860052 (to M.A.K.); and NIH Training Grants T32-HL105338 and T32-GM007250 (to M.A.K.).

  • The online version of this article contains supplemental material.

  • Abbreviations used in this article:

    ASC
    apoptosis-associated speck-like protein with a CARD
    BMDC
    bone marrow–derived dendritic cell
    BMDM
    bone marrow–derived macrophage
    BSS
    balanced salt solution
    DSS
    disuccinimidyl suberate
    ECM
    extracellular medium
    EthD
    ethidium homodimer
    gRNA
    guide RNA
    Gsdmd
    gasdermin D
    iBMDM
    immortalized BMDM
    LDH
    lactate dehydrogenase
    MLKL
    mixed lineage kinase domain-like
    NG
    nigericin
    NTG
    nontargeting gRNA
    Panx1
    pannexin-1
    PM
    plasma membrane
    Pro2+
    propidium2+
    ROS
    reactive oxygen species
    TcdB
    Clostridium difficile toxin B
    WT
    wild-type.

  • Received April 20, 2016.
  • Accepted June 4, 2016.
  • Copyright © 2016 by The American Association of Immunologists, Inc.

References

  1. ↵
    1. Shi J.,
    2. Y. Zhao,
    3. Y. Wang,
    4. W. Gao,
    5. J. Ding,
    6. P. Li,
    7. L. Hu,
    8. F. Shao
    . 2014. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514: 187–192.
    OpenUrlPubMed
  2. ↵
    1. Carta S.,
    2. R. Lavieri,
    3. A. Rubartelli
    . 2013. Different members of the IL-1 family come out in different ways: DAMPs vs. cytokines? Front. Immunol. 4: 123.
    OpenUrlPubMed
  3. ↵
    1. Dubyak G. R.
    2012. P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell. Microbiol. 14: 1697–1706.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Gaidt M. M.,
    2. T. S. Ebert,
    3. D. Chauhan,
    4. T. Schmidt,
    5. J. L. Schmid-Burgk,
    6. F. Rapino,
    7. A. A. Robertson,
    8. M. A. Cooper,
    9. T. Graf,
    10. V. Hornung
    . 2016. Human monocytes engage an alternative inflammasome pathway. Immunity 44: 833–846.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Karmakar M.,
    2. M. A. Katsnelson,
    3. G. R. Dubyak,
    4. E. Pearlman
    . 2016. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP. Nat. Commun. 7: 10555.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Miao E. A.,
    2. I. A. Leaf,
    3. P. M. Treuting,
    4. D. P. Mao,
    5. M. Dors,
    6. A. Sarkar,
    7. S. E. Warren,
    8. M. D. Wewers,
    9. A. Aderem
    . 2010. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11: 1136–1142.
    OpenUrlCrossRefPubMed
  7. ↵
    1. von Moltke J.,
    2. N. J. Trinidad,
    3. M. Moayeri,
    4. A. F. Kintzer,
    5. S. B. Wang,
    6. N. van Rooijen,
    7. C. R. Brown,
    8. B. A. Krantz,
    9. S. H. Leppla,
    10. K. Gronert,
    11. R. E. Vance
    . 2012. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490: 107–111.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Kayagaki N.,
    2. S. Warming,
    3. M. Lamkanfi,
    4. L. Vande Walle,
    5. S. Louie,
    6. J. Dong,
    7. K. Newton,
    8. Y. Qu,
    9. J. Liu,
    10. S. Heldens,
    11. et al
    . 2011. Non-canonical inflammasome activation targets caspase-11. Nature 479: 117–121.
    OpenUrlCrossRefPubMed
    1. Kayagaki N.,
    2. M. T. Wong,
    3. I. B. Stowe,
    4. S. R. Ramani,
    5. L. C. Gonzalez,
    6. S. Akashi-Takamura,
    7. K. Miyake,
    8. J. Zhang,
    9. W. P. Lee,
    10. A. Muszyński,
    11. et al
    . 2013. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341: 1246–1249.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Hagar J. A.,
    2. D. A. Powell,
    3. Y. Aachoui,
    4. R. K. Ernst,
    5. E. A. Miao
    . 2013. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341: 1250–1253.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Doitsh G.,
    2. N. L. Galloway,
    3. X. Geng,
    4. Z. Yang,
    5. K. M. Monroe,
    6. O. Zepeda,
    7. P. W. Hunt,
    8. H. Hatano,
    9. S. Sowinski,
    10. I. Muñoz-Arias,
    11. W. C. Greene
    . 2014. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505: 509–514.
    OpenUrlPubMed
  11. ↵
    1. Franklin B. S.,
    2. L. Bossaller,
    3. D. De Nardo,
    4. J. M. Ratter,
    5. A. Stutz,
    6. G. Engels,
    7. C. Brenker,
    8. M. Nordhoff,
    9. S. R. Mirandola,
    10. A. Al-Amoudi,
    11. et al
    . 2014. The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat. Immunol. 15: 727–737.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Shi J.,
    2. Y. Zhao,
    3. K. Wang,
    4. X. Shi,
    5. Y. Wang,
    6. H. Huang,
    7. Y. Zhuang,
    8. T. Cai,
    9. F. Wang,
    10. F. Shao
    . 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526: 660–665.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Kayagaki N.,
    2. I. B. Stowe,
    3. B. L. Lee,
    4. K. O’Rourke,
    5. K. Anderson,
    6. S. Warming,
    7. T. Cuellar,
    8. B. Haley,
    9. M. Roose-Girma,
    10. Q. T. Phung,
    11. et al
    . 2015. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526: 666–671.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Tamura M.,
    2. S. Tanaka,
    3. T. Fujii,
    4. A. Aoki,
    5. H. Komiyama,
    6. K. Ezawa,
    7. K. Sumiyama,
    8. T. Sagai,
    9. T. Shiroishi
    . 2007. Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner. Genomics 89: 618–629.
    OpenUrlCrossRefPubMed
  15. ↵
    1. He W. T.,
    2. H. Wan,
    3. L. Hu,
    4. P. Chen,
    5. X. Wang,
    6. Z. Huang,
    7. Z. H. Yang,
    8. C. Q. Zhong,
    9. J. Han
    . 2015. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 25: 1285–1298.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Broz P.,
    2. J. von Moltke,
    3. J. W. Jones,
    4. R. E. Vance,
    5. D. M. Monack
    . 2010. Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 8: 471–483.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Jorgensen I.,
    2. E. A. Miao
    . 2015. Pyroptotic cell death defends against intracellular pathogens. Immunol. Rev. 265: 130–142.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Fink S. L.,
    2. B. T. Cookson
    . 2006. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell. Microbiol. 8: 1812–1825.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Qu Y.,
    2. L. Ramachandra,
    3. S. Mohr,
    4. L. Franchi,
    5. C. V. Harding,
    6. G. Nunez,
    7. G. R. Dubyak
    . 2009. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J. Immunol. 182: 5052–5062.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Li P.,
    2. H. Allen,
    3. S. Banerjee,
    4. S. Franklin,
    5. L. Herzog,
    6. C. Johnston,
    7. J. McDowell,
    8. M. Paskind,
    9. L. Rodman,
    10. J. Salfeld,
    11. et al
    . 1995. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80: 401–411.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Sanjana N. E.,
    2. O. Shalem,
    3. F. Zhang
    . 2014. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11: 783–784.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Shalem O.,
    2. N. E. Sanjana,
    3. E. Hartenian,
    4. X. Shi,
    5. D. A. Scott,
    6. T. S. Mikkelsen,
    7. D. Heckl,
    8. B. L. Ebert,
    9. D. E. Root,
    10. J. G. Doench,
    11. F. Zhang
    . 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343: 84–87.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Antonopoulos C.,
    2. H. M. Russo,
    3. C. El Sanadi,
    4. B. N. Martin,
    5. X. Li,
    6. W. J. Kaiser,
    7. E. S. Mocarski,
    8. G. R. Dubyak
    . 2015. Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling. J. Biol. Chem. 290: 20167–20184.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Katsnelson M. A.,
    2. L. G. Rucker,
    3. H. M. Russo,
    4. G. R. Dubyak
    . 2015. K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling. J. Immunol. 194: 3937–3952.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Grynkiewicz G.,
    2. M. Poenie,
    3. R. Y. Tsien
    . 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440–3450.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Boyd-Tressler A.,
    2. S. Penuela,
    3. D. W. Laird,
    4. G. R. Dubyak
    . 2014. Chemotherapeutic drugs induce ATP release via caspase-gated pannexin-1 channels and a caspase/pannexin-1-independent mechanism. J. Biol. Chem. 289: 27246–27263.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Bergsbaken T.,
    2. S. L. Fink,
    3. A. B. den Hartigh,
    4. W. P. Loomis,
    5. B. T. Cookson
    . 2011. Coordinated host responses during pyroptosis: caspase-1-dependent lysosome exocytosis and inflammatory cytokine maturation. J. Immunol. 187: 2748–2754.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Case C. L.,
    2. L. J. Kohler,
    3. J. B. Lima,
    4. T. Strowig,
    5. M. R. de Zoete,
    6. R. A. Flavell,
    7. D. S. Zamboni,
    8. C. R. Roy
    . 2013. Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila. Proc. Natl. Acad. Sci. USA 110: 1851–1856.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Pétrilli V.,
    2. S. Papin,
    3. C. Dostert,
    4. A. Mayor,
    5. F. Martinon,
    6. J. Tschopp
    . 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14: 1583–1589.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Muñoz-Planillo R.,
    2. P. Kuffa,
    3. G. Martínez-Colón,
    4. B. L. Smith,
    5. T. M. Rajendiran,
    6. G. Núñez
    . 2013. K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38: 1142–1153.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Lyras D.,
    2. J. R. O’Connor,
    3. P. M. Howarth,
    4. S. P. Sambol,
    5. G. P. Carter,
    6. T. Phumoonna,
    7. R. Poon,
    8. V. Adams,
    9. G. Vedantam,
    10. S. Johnson,
    11. et al
    . 2009. Toxin B is essential for virulence of Clostridium difficile. Nature 458: 1176–1179.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Carter G. P.,
    2. J. I. Rood,
    3. D. Lyras
    . 2012. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 20: 21–29.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Voth D. E.,
    2. J. D. Ballard
    . 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18: 247–263.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Kelly C. P.,
    2. J. T. LaMont
    . 2008. Clostridium difficile--more difficult than ever. N. Engl. J. Med. 359: 1932–1940.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Xu H.,
    2. J. Yang,
    3. W. Gao,
    4. L. Li,
    5. P. Li,
    6. L. Zhang,
    7. Y. N. Gong,
    8. X. Peng,
    9. J. J. Xi,
    10. S. Chen,
    11. et al
    . 2014. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513: 237–241.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Fink S. L.,
    2. B. T. Cookson
    . 2007. Pyroptosis and host cell death responses during Salmonella infection. Cell. Microbiol. 9: 2562–2570.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Brennan M. A.,
    2. B. T. Cookson
    . 2000. Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol. Microbiol. 38: 31–40.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Verhoef P. A.,
    2. S. B. Kertesy,
    3. M. Estacion,
    4. W. P. Schilling,
    5. G. R. Dubyak
    . 2004. Maitotoxin induces biphasic interleukin-1beta secretion and membrane blebbing in murine macrophages. Mol. Pharmacol. 66: 909–920.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Verhoef P. A.,
    2. S. B. Kertesy,
    3. K. Lundberg,
    4. J. M. Kahlenberg,
    5. G. R. Dubyak
    . 2005. Inhibitory effects of chloride on the activation of caspase-1, IL-1beta secretion, and cytolysis by the P2X7 receptor. J. Immunol. 175: 7623–7634.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Estacion M.,
    2. J. S. Weinberg,
    3. W. G. Sinkins,
    4. W. P. Schilling
    . 2003. Blockade of maitotoxin-induced endothelial cell lysis by glycine and L-alanine. Am. J. Physiol. Cell Physiol. 284: C1006–C1020.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Schilling W. P.,
    2. D. Snyder,
    3. W. G. Sinkins,
    4. M. Estacion
    . 2006. Palytoxin-induced cell death cascade in bovine aortic endothelial cells. Am. J. Physiol. Cell Physiol. 291: C657–C667.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Ghiringhelli F.,
    2. L. Apetoh,
    3. A. Tesniere,
    4. L. Aymeric,
    5. Y. Ma,
    6. C. Ortiz,
    7. K. Vermaelen,
    8. T. Panaretakis,
    9. G. Mignot,
    10. E. Ullrich,
    11. et al
    . 2009. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15: 1170–1178.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Aymeric L.,
    2. L. Apetoh,
    3. F. Ghiringhelli,
    4. A. Tesniere,
    5. I. Martins,
    6. G. Kroemer,
    7. M. J. Smyth,
    8. L. Zitvogel
    . 2010. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 70: 855–858.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Arandjelovic S.,
    2. K. S. Ravichandran
    . 2015. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16: 907–917.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Lamkanfi M.,
    2. T. D. Kanneganti,
    3. P. Van Damme,
    4. T. Vanden Berghe,
    5. I. Vanoverberghe,
    6. J. Vandekerckhove,
    7. P. Vandenabeele,
    8. K. Gevaert,
    9. G. Núñez
    . 2008. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol. Cell. Proteomics 7: 2350–2363.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Yang D.,
    2. Y. He,
    3. R. Muñoz-Planillo,
    4. Q. Liu,
    5. G. Núñez
    . 2015. Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 43: 923–932.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Poon I. K.,
    2. Y. H. Chiu,
    3. A. J. Armstrong,
    4. J. M. Kinchen,
    5. I. J. Juncadella,
    6. D. A. Bayliss,
    7. K. S. Ravichandran
    . 2014. Unexpected link between an antibiotic, pannexin channels and apoptosis. Nature 507: 329–334.
    OpenUrlCrossRefPubMed
    1. Chiu Y. H.,
    2. K. S. Ravichandran,
    3. D. A. Bayliss
    . 2014. Intrinsic properties and regulation of Pannexin 1 channel. Channels (Austin) 8: 103–109.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Chekeni F. B.,
    2. M. R. Elliott,
    3. J. K. Sandilos,
    4. S. F. Walk,
    5. J. M. Kinchen,
    6. E. R. Lazarowski,
    7. A. J. Armstrong,
    8. S. Penuela,
    9. D. W. Laird,
    10. G. S. Salvesen,
    11. et al
    . 2010. Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis. Nature 467: 863–867.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Wu L. J.,
    2. T. B. Sweet,
    3. D. E. Clapham
    . 2010. International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol. Rev. 62: 381–404.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Hansen D. B.,
    2. Z. C. Ye,
    3. K. Calloe,
    4. T. H. Braunstein,
    5. J. P. Hofgaard,
    6. B. R. Ransom,
    7. M. S. Nielsen,
    8. N. MacAulay
    . 2014. Activation, permeability, and inhibition of astrocytic and neuronal large pore (hemi)channels. J. Biol. Chem. 289: 26058–26073.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Compan V.,
    2. A. Baroja-Mazo,
    3. G. López-Castejón,
    4. A. I. Gomez,
    5. C. M. Martínez,
    6. D. Angosto,
    7. M. T. Montero,
    8. A. S. Herranz,
    9. E. Bazán,
    10. D. Reimers,
    11. et al
    . 2012. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37: 487–500.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Lee G. S.,
    2. N. Subramanian,
    3. A. I. Kim,
    4. I. Aksentijevich,
    5. R. Goldbach-Mansky,
    6. D. B. Sacks,
    7. R. N. Germain,
    8. D. L. Kastner,
    9. J. J. Chae
    . 2012. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492: 123–127.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Lansman J. B.
    1990. Blockade of current through single calcium channels by trivalent lanthanide cations. Effect of ionic radius on the rates of ion entry and exit. J. Gen. Physiol. 95: 679–696.
    OpenUrlAbstract/FREE Full Text
    1. Mlinar B.,
    2. J. J. Enyeart
    . 1993. Block of current through T-type calcium channels by trivalent metal cations and nickel in neural rat and human cells. J. Physiol. 469: 639–652.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Malasics A.,
    2. D. Boda,
    3. M. Valiskó,
    4. D. Henderson,
    5. D. Gillespie
    . 2010. Simulations of calcium channel block by trivalent cations: Gd(3+) competes with permeant ions for the selectivity filter. Biochim. Biophys. Acta 1798: 2013–2021.
    OpenUrlPubMed
  55. ↵
    1. Ermakov Y. A.,
    2. K. Kamaraju,
    3. K. Sengupta,
    4. S. Sukharev
    . 2010. Gadolinium ions block mechanosensitive channels by altering the packing and lateral pressure of anionic lipids. Biophys. J. 98: 1018–1027.
    OpenUrlCrossRefPubMed
  56. ↵
    1. Anishkin A.,
    2. S. H. Loukin,
    3. J. Teng,
    4. C. Kung
    . 2014. Feeling the hidden mechanical forces in lipid bilayer is an original sense. Proc. Natl. Acad. Sci. USA 111: 7898–7905.
    OpenUrlAbstract/FREE Full Text
  57. ↵
    1. Sandilos J. K.,
    2. Y. H. Chiu,
    3. F. B. Chekeni,
    4. A. J. Armstrong,
    5. S. F. Walk,
    6. K. S. Ravichandran,
    7. D. A. Bayliss
    . 2012. Pannexin 1, an ATP release channel, is activated by caspase cleavage of its pore-associated C-terminal autoinhibitory region. J. Biol. Chem. 287: 11303–11311.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    1. Sheedy F. J.,
    2. A. Grebe,
    3. K. J. Rayner,
    4. P. Kalantari,
    5. B. Ramkhelawon,
    6. S. B. Carpenter,
    7. C. E. Becker,
    8. H. N. Ediriweera,
    9. A. E. Mullick,
    10. D. T. Golenbock,
    11. et al
    . 2013. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 14: 812–820.
    OpenUrlCrossRefPubMed
  59. ↵
    1. Desai B. N.,
    2. G. Krapivinsky,
    3. B. Navarro,
    4. L. Krapivinsky,
    5. B. C. Carter,
    6. S. Febvay,
    7. M. Delling,
    8. A. Penumaka,
    9. I. S. Ramsey,
    10. Y. Manasian,
    11. D. E. Clapham
    . 2012. Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev. Cell 22: 1149–1162.
    OpenUrlCrossRefPubMed
  60. ↵
    1. Knowles H.,
    2. Y. Li,
    3. A. L. Perraud
    . 2013. The TRPM2 ion channel, an oxidative stress and metabolic sensor regulating innate immunity and inflammation. Immunol. Res. 55: 241–248.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Zhou R.,
    2. A. S. Yazdi,
    3. P. Menu,
    4. J. Tschopp
    . 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221–225.
    OpenUrlCrossRefPubMed
  62. ↵
    1. Zhong Z.,
    2. Y. Zhai,
    3. S. Liang,
    4. Y. Mori,
    5. R. Han,
    6. F. S. Sutterwala,
    7. L. Qiao
    . 2013. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat. Commun. 4: 1611.
    OpenUrlCrossRefPubMed
  63. ↵
    1. Chubanov V.,
    2. M. Mederos y Schnitzler,
    3. M. Meißner,
    4. S. Schäfer,
    5. K. Abstiens,
    6. T. Hofmann,
    7. T. Gudermann
    . 2012. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br. J. Pharmacol. 166: 1357–1376.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Chubanov V.,
    2. S. Schäfer,
    3. S. Ferioli,
    4. T. Gudermann
    . 2014. Natural and synthetic modulators of the TRPM7 channel. Cells 3: 1089–1101.
    OpenUrlCrossRef
  65. ↵
    Katsnelson, M. A., K. M. Lozada-Soto, H. M. Russo, B. A. Miller, and G. R. Dubyak. 2016. NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx. Am. J. Physiol. Cell Physiol. ajpcell.00298.2015.
  66. ↵
    1. Cai Z.,
    2. S. Jitkaew,
    3. J. Zhao,
    4. H. C. Chiang,
    5. S. Choksi,
    6. J. Liu,
    7. Y. Ward,
    8. L. G. Wu,
    9. Z. G. Liu
    . 2014. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16: 55–65.
    OpenUrlCrossRefPubMed
  67. ↵
    1. Wang H.,
    2. L. Sun,
    3. L. Su,
    4. J. Rizo,
    5. L. Liu,
    6. L. F. Wang,
    7. F. S. Wang,
    8. X. Wang
    . 2014. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54: 133–146.
    OpenUrlCrossRefPubMed
  68. ↵
    1. Dondelinger Y.,
    2. W. Declercq,
    3. S. Montessuit,
    4. R. Roelandt,
    5. A. Goncalves,
    6. I. Bruggeman,
    7. P. Hulpiau,
    8. K. Weber,
    9. C. A. Sehon,
    10. R. W. Marquis,
    11. et al
    . 2014. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Reports 7: 971–981.
    OpenUrlCrossRefPubMed
  69. ↵
    1. Su L.,
    2. B. Quade,
    3. H. Wang,
    4. L. Sun,
    5. X. Wang,
    6. J. Rizo
    . 2014. A plug release mechanism for membrane permeation by MLKL. Structure 22: 1489–1500.
    OpenUrlCrossRefPubMed
  70. ↵
    1. Ma Z.,
    2. A. P. Siebert,
    3. K. H. Cheung,
    4. R. J. Lee,
    5. B. Johnson,
    6. A. S. Cohen,
    7. V. Vingtdeux,
    8. P. Marambaud,
    9. J. K. Foskett
    . 2012. Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability. Proc. Natl. Acad. Sci. USA 109: E1963–E1971.
    OpenUrlAbstract/FREE Full Text
  71. ↵
    1. Siebert A. P.,
    2. Z. Ma,
    3. J. D. Grevet,
    4. A. Demuro,
    5. I. Parker,
    6. J. K. Foskett
    . 2013. Structural and functional similarities of calcium homeostasis modulator 1 (CALHM1) ion channel with connexins, pannexins, and innexins. J. Biol. Chem. 288: 6140–6153.
    OpenUrlAbstract/FREE Full Text
  72. ↵
    1. Taruno A.,
    2. V. Vingtdeux,
    3. M. Ohmoto,
    4. Z. Ma,
    5. G. Dvoryanchikov,
    6. A. Li,
    7. L. Adrien,
    8. H. Zhao,
    9. S. Leung,
    10. M. Abernethy,
    11. et al
    . 2013. CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes. Nature 495: 223–226.
    OpenUrlCrossRefPubMed
  73. ↵
    1. Lin P. H.,
    2. H. Y. Lin,
    3. C. C. Kuo,
    4. L. T. Yang
    . 2015. N-terminal functional domain of Gasdermin A3 regulates mitochondrial homeostasis via mitochondrial targeting. J. Biomed. Sci. 22: 44.
    OpenUrlCrossRefPubMed
  74. ↵
    1. Yu J.,
    2. H. Nagasu,
    3. T. Murakami,
    4. H. Hoang,
    5. L. Broderick,
    6. H. M. Hoffman,
    7. T. Horng
    . 2014. Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc. Natl. Acad. Sci. USA 111: 15514–15519.
    OpenUrlAbstract/FREE Full Text
  75. ↵
    1. Jain M.,
    2. R. Nilsson,
    3. S. Sharma,
    4. N. Madhusudhan,
    5. T. Kitami,
    6. A. L. Souza,
    7. R. Kafri,
    8. M. W. Kirschner,
    9. C. B. Clish,
    10. V. K. Mootha
    . 2012. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336: 1040–1044.
    OpenUrlAbstract/FREE Full Text
  76. ↵
    1. Singer I. I.,
    2. S. Scott,
    3. J. Chin,
    4. E. K. Bayne,
    5. G. Limjuco,
    6. J. Weidner,
    7. D. K. Miller,
    8. K. Chapman,
    9. M. J. Kostura
    . 1995. The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med. 182: 1447–1459.
    OpenUrlAbstract/FREE Full Text
  77. ↵
    1. Ding J.,
    2. K. Wang,
    3. W. Liu,
    4. Y. She,
    5. Q. Sun,
    6. J. Shi,
    7. H. Sun,
    8. D.-C. Wang,
    9. F. Shao
    . 2016. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. DOI: 10.1038/nature18590.
PreviousNext
Back to top

In this issue

The Journal of Immunology: 197 (4)
The Journal of Immunology
Vol. 197, Issue 4
15 Aug 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides
Hana M. Russo, Joseph Rathkey, Andrea Boyd-Tressler, Michael A. Katsnelson, Derek W. Abbott, George R. Dubyak
The Journal of Immunology August 15, 2016, 197 (4) 1353-1367; DOI: 10.4049/jimmunol.1600699

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides
Hana M. Russo, Joseph Rathkey, Andrea Boyd-Tressler, Michael A. Katsnelson, Derek W. Abbott, George R. Dubyak
The Journal of Immunology August 15, 2016, 197 (4) 1353-1367; DOI: 10.4049/jimmunol.1600699
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • IFIT5 Negatively Regulates the Type I IFN Pathway by Disrupting TBK1–IKKε–IRF3 Signalosome and Degrading IRF3 and IKKε
  • Proprotein Convertase Is the Highest-Level Activator of the Alternative Complement Pathway in the Blood
  • Interplay between NOD1 and TLR4 Receptors in Macrophages: Nonsynergistic Activation of Signaling Pathways Results in Synergistic Induction of Proinflammatory Gene Expression
Show more INNATE IMMUNITY AND INFLAMMATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606